var title_f6_16_6400="Mulberry molar";
var content_f6_16_6400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital syphilis: Mulberry molar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of the Female Genital Tract. Lippincott Williams &amp; Wilkins, Philadelphia 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6400=[""].join("\n");
var outline_f6_16_6400=null;
var title_f6_16_6401="Correct position forceps";
var content_f6_16_6401=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Correct placement of the forceps blades on the fetal head",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: James R. Scott, Ronald S. Gibbs, Danforth's Obstetrics and Gynecology, Ninth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6401=[""].join("\n");
var outline_f6_16_6401=null;
var title_f6_16_6402="Incision for axillary dissection";
var content_f6_16_6402=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52834&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Incision for axillary dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axillary incision is sketched onto the skin using land-marks mentioned in the text.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6402=[""].join("\n");
var outline_f6_16_6402=null;
var title_f6_16_6403="Prismatic structure of enamel";
var content_f6_16_6403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scanning electron micrograph of dental enamel",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 280px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This scanning electron micrograph shows the prismatic structure of human dental enamel.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wright JT. Normal formation and development defects of the human dentition. Pediatr Clin North Am 2000; 47:975. Copyright &copy; 2000 WB Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6403=[""].join("\n");
var outline_f6_16_6403=null;
var title_f6_16_6404="Doppler ultrasound of the basilar artery";
var content_f6_16_6404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Doppler ultrasound of the basilar artery in a newborn with hypoxic-ischemic brain injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Doppler ultrasound of the basilar artery (top center image) with systole/diastole profile (bottom display) in a term newborn with hypoxic-ischemic brain injury. The resistive index (RI) of 0.35 is characteristic of the reperfusion edema phase and is associated with a poor neurodevelopmental outcome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6404=[""].join("\n");
var outline_f6_16_6404=null;
var title_f6_16_6405="Abdominal hysterectomy";
var content_f6_16_6405=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Abdominal hysterectomy (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?6/16/6405/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6405/contributors\" id=\"au5417\">",
"       Thomas G Stovall, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6405/contributors\" id=\"au5145\">",
"       William J Mann, Jr, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?6/16/6405/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6405/contributors\" id=\"se2521\">",
"       Howard T Sharp, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?6/16/6405/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6405/contributors\" id=\"de1930\">",
"       Sandy J Falk, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?6/16/6405?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ABDOMINAL HYSTERECTOMY OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Abdominal hysterectomy is a surgical procedure in which the uterus is removed through an incision in the lower abdomen (",
"     <a class=\"graphic graphic_figure graphicRef55363 \" href=\"UTD.htm?38/29/39391\">",
"      figure 1",
"     </a>",
"     ). One or both ovaries and fallopian tubes may also be removed during the procedure (",
"     <a class=\"graphic graphic_figure graphicRef57901 \" href=\"UTD.htm?37/40/38534\">",
"      figure 2",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      FEMALE ANATOMY",
"     </span>",
"    </p>",
"    <p>",
"     A brief review of female reproductive anatomy may be of help in understanding hysterectomy.",
"    </p>",
"    <p>",
"     The uterus is a hollow, pear-shaped muscular organ located in the lower abdomen and pelvis (",
"     <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"      figure 3",
"     </a>",
"     ). At the upper end of the uterus, the fallopian tubes open on each side. The outer end of each tube lays next to an ovary. The ovaries lay next to and slightly behind the uterus.",
"    </p>",
"    <p>",
"     At its lower end, the uterus narrows and opens into the vagina. The lower end of the uterus is called the cervix.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      REASONS FOR ABDOMINAL HYSTERECTOMY",
"     </span>",
"    </p>",
"    <p>",
"     A hysterectomy may be recommended for a number of conditions. For some of these conditions, there may be an alternative to hysterectomy, described below. (See",
"     <a class=\"local\" href=\"#H28\">",
"      'Alternatives to hysterectomy'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Abnormal uterine bleeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;Excessive uterine bleeding, called menorrhagia, can lead to anemia (low blood iron count), fatigue, and contribute to missed days at work or school. Menorrhagia is generally defined as bleeding that lasts longer than seven days or saturates more than one pad per hour for several hours. Abnormal uterine bleeding (or any uterine bleeding after menopause) can also be a sign of uterine cancer. All women with these symptoms should undergo evaluation.",
"    </p>",
"    <p>",
"     Heavy or irregular bleeding are generally treated first with medication or other surgical alternatives to hysterectomy. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/35/23094?source=see_link\">",
"      \"Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics)\"",
"     </a>",
"     .) However, abnormal uterine bleeding that does not improve with conservative treatments may require hysterectomy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Fibroids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Fibroids (also known as leiomyoma) are noncancerous growths of uterine muscle that occur in up to one-third of all women. Fibroids may become larger during pregnancy, and typically shrink after menopause. They may cause excessive bleeding and pelvic pain or pressure. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=see_link\">",
"      \"Patient information: Uterine fibroids (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Pelvic organ prolapse",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pelvic organ prolapse occurs due to stretching and weakening of the pelvic muscles and ligaments. This allows the uterus to fall (or prolapse) into the vagina. Prolapse is more common in women who have been pregnant, had vaginal childbirth, and in those with certain genetic factors, lifestyle factors (repeated heavy lifting over the lifetime), or chronic constipation.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Cervical abnormalities",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hysterectomy is rarely needed for severe cervical precancer that does not resolve after other procedures (such as cone biopsy). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"      \"Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"      \"Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Endometrial hyperplasia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Endometrial hyperplasia is the term used to describe excessive growth of the endometrium (the tissue that lines the uterus). It can sometimes lead to endometrial cancer. Although endometrial hyperplasia can often be treated with medication, a hysterectomy is sometimes needed or preferred to medical therapy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Cancer",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cancer of the uterus (endometrium), cervix, or ovaries may require hysterectomy. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=see_link\">",
"      \"Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=see_link\">",
"      \"Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/34/41507?source=see_link\">",
"      \"Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Severe bleeding after childbirth",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hysterectomy may rarely be required in women who have uncontrollable bleeding after childbirth.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Chronic pelvic pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Chronic pelvic pain can be due to the effects of endometriosis or scarring (adhesions) in the pelvis and between pelvic organs. However, pelvic pain can also be caused by other sources, including the gastrointestinal and urinary systems. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"      \"Patient information: Chronic pelvic pain in women (Beyond the Basics)\"",
"     </a>",
"     .) It is important for a woman with pelvic pain to ask about the probability that her pain will improve after hysterectomy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      PRE-OPERATIVE PLANNING AND EVALUATION",
"     </span>",
"    </p>",
"    <p>",
"     Before surgery, there are two main decisions that need to be made about the procedure: whether the cervix should be removed and whether the ovaries and tubes should be removed. If the ovaries are removed, a woman may need to decide if she should take estrogen replacement therapy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Supracervical/subtotal hysterectomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;A standard abdominal hysterectomy includes removal of the entire uterus and cervix. However, there are situations in which the entire uterus is not removed. A supracervical, subtotal, or partial hysterectomy refers to a procedure in which the cervix is left in place, while the top of the uterus is removed. Supracervical hysterectomy may be done if difficulties arise during surgery, making removal of the cervix complicated. Prior to planned supracervical hysterectomy, you should discuss the risks and benefits of leaving the cervix in place with your doctor.",
"    </p>",
"    <p>",
"     Women who undergo supracervical hysterectomy must continue to have routine screening (Pap smear) for cervical cancer. Some women continue to have menstrual bleeding since the retained cervix is attached to a small remaining portion of the uterus.",
"    </p>",
"    <p>",
"     There was initial concern that removing the cervix would interfere with sexual satisfaction. However, studies have demonstrated that sexual satisfaction does not appear to differ after hysterectomy between women with and without a cervix.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Removal of ovaries",
"     </span>",
"     &nbsp;&mdash;&nbsp;The ovaries may be removed during hysterectomy, a procedure known as an oophorectomy. Oophorectomy is not always required; the decision depends upon several considerations.",
"    </p>",
"    <p>",
"     Premenopausal women may decide to keep the ovaries to provide a continued, natural source of hormones, including estrogen, progesterone, and testosterone. These hormones are important in maintaining sexual interest and preventing hot flashes and loss of bone density loss. On the other hand, women who have menstrual cycle-related migraines, epilepsy, or severe premenstrual syndrome (PMS) may have an improvement in symptoms when hormone levels are reduced by removing the ovaries. Discuss the risks and preferences of removing the ovaries with your doctor before surgery.",
"    </p>",
"    <p>",
"     Postmenopausal women are often advised to have their ovaries removed because of a small risk of developing ovarian cancer at some point during their lifetime. The benefits of removing or keeping ovaries should be discussed with a physician.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Estrogen therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Estrogen therapy (ET) may be recommended after surgery for women who have not reached menopause who had their ovaries removed. ET can help to prevent hot flashes, night sweats, and loss of bone density, which may occur when the ovaries are surgically removed. Women who plan to use ET should talk with their clinician about the risks and benefits, and about how long to use this treatment. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/63/12276?source=see_link\">",
"      \"Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Women who have completed menopause generally do not require ET after hysterectomy. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/4/32835?source=see_link\">",
"      \"Patient information: Postmenopausal hormone therapy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Pre-operative testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Standard pre-operative testing may include a physical examination, EKG, chest x-ray, and blood testing, depending upon age and other medical conditions.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      ABDOMINAL HYSTERECTOMY PROCEDURE",
"     </span>",
"    </p>",
"    <p>",
"     Abdominal hysterectomy is performed in a hospital setting, and generally requires approximately two hours in the operating room. Patients are given general or spinal anesthesia plus sedation so that they feel no pain. Heart rate, blood pressure, blood loss, and respiration are closely observed throughout the procedure. After surgery, patients are transferred to the recovery room (also known as the post-anesthesia care unit) so that they can be monitored while waking up. Most patients will then be transferred to a hospital room, where they will spend one to two nights.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      ABDOMINAL HYSTERECTOMY COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     A number of complications can occur as a result of hysterectomy. Fortunately, most can be easily managed and do not cause long-term problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Hemorrhage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Excessive bleeding (hemorrhage) occurs in a small number of cases and may require a return to the operating room to identify and stop the bleeding.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Low-grade fever is common after hysterectomy, is not always caused by infection, and usually resolves without treatment. However, a high or persistent fever may signal an infection. Serious infection occurs in less than ten percent of women, and can usually be treated with intravenous antibiotics. Much less commonly, patients require another surgical procedure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Constipation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Constipation occurs in most women following hysterectomy, and can usually be controlled with a regimen of stool softeners, dietary fiber, and laxatives.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Urinary retention",
"     </span>",
"     &nbsp;&mdash;&nbsp;Urinary retention, or the inability to pass urine, can occur after abdominal hysterectomy. It is more common in women who have vaginal hysterectomy. (See",
"     <a class=\"local\" href=\"#H28\">",
"      'Alternatives to hysterectomy'",
"     </a>",
"     below.) Urine can be drained using a catheter until retention resolves, usually within 24 to 48 hours.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Blood clots",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pelvic surgery increases the risk of developing blood clots in the large veins of the leg or lung. The risk is increased for approximately six weeks after surgery. Medications may be given to some women to prevent blood clots. In addition, women taking oral contraceptives or hormone replacement should ideally discontinue them prior to surgery since they can further increase the risk of blood clots. Women who are sexually active and premenopausal should use alternative methods of birth control (e.g. condoms) to prevent pregnancy before surgery. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      \"Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Damage to adjacent organs",
"     </span>",
"     &nbsp;&mdash;&nbsp;The urinary bladder, ureters (small tubes leading from the kidneys to the bladder), and large and small intestines are located in the lower abdomen and pelvis and can be injured during hysterectomy. Injury occurs in less than one percent of all women undergoing hysterectomy, and can usually be detected and corrected at the time of surgery. If detected after surgery, another operation may be needed.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Early menopause",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women who have undergone hysterectomy may experience menopause earlier than the average age of menopause (age 51). This may be due to an interruption in blood flow to the ovaries as a result of removing the uterus.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H26\">",
"     <span class=\"h1\">",
"      RECOVERY AFTER ABDOMINAL HYSTERECTOMY",
"     </span>",
"    </p>",
"    <p>",
"     Fluids and food are generally offered soon after surgery. Intravenous (IV) fluids may be administered during the first day, particularly if there is nausea or vomiting. Pain medicine is given as needed, either intravenously, or by intramuscular (IM) injection, or as a pill. Patients are encouraged to resume their normal daily activities as soon as possible. Being active is particularly important since it helps to prevent complications, such as blood clots, pneumonia, and gas pains.",
"    </p>",
"    <p>",
"     More information about recovery from hysterectomy is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=see_link\">",
"      \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h1\">",
"      LIFE AFTER ABDOMINAL HYSTERECTOMY",
"     </span>",
"    </p>",
"    <p>",
"     Studies of women's response to hysterectomy show that most women are satisfied with their results (",
"     <a class=\"graphic graphic_table graphicRef68886 \" href=\"UTD.htm?21/12/21707\">",
"      table 1",
"     </a>",
"     ). Most reported improvement in symptoms, such as pain and vaginal bleeding.",
"    </p>",
"    <p>",
"     Sexual function and enjoyment, interest in sex, and pain with sex were improved for most women. However, this improvement may depend upon several factors, including the age of a woman at the time of surgery, the reason for surgery, and history of any prior difficulties with mood.",
"    </p>",
"    <p>",
"     Younger women may grieve after hysterectomy due to their loss of fertility. A woman who has new feelings of sadness, anxiety, or depression after surgery should speak with her healthcare provider. These feelings may be treated by talking with a therapist, with antidepressant medication, or may resolve with time. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/63/12276?source=see_link\">",
"      \"Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      ALTERNATIVES TO HYSTERECTOMY",
"     </span>",
"    </p>",
"    <p>",
"     Women who wish to avoid or postpone hysterectomy may be able to use medications or less invasive surgical procedures. Medical and surgical alternatives to hysterectomy depend upon the underlying disorder. The decision as to which treatment is \"best\" should be based upon a woman's particular medical problem, all available treatment options, and the risks and benefits of each type of treatment.",
"    </p>",
"    <p>",
"     Some alternatives to abdominal hysterectomy include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In some cases the uterus may be removed through the vagina, avoiding the need for an incision in the abdomen. This procedure is called a vaginal hysterectomy. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?33/48/34564?source=see_link\">",
"        \"Patient information: Vaginal hysterectomy (Beyond the Basics)\"",
"       </a>",
"       .) A vaginal approach may be used if the uterus is not too big, there is not too much scar tissue, and if the condition prompting the surgery is benign and limited to the uterus. Most women can return to normal activities sooner after a vaginal hysterectomy than after an abdominal hysterectomy.",
"      </li>",
"      <li>",
"       Uterine artery embolization and myomectomy may be used to treat symptomatic leiomyoma (fibroids). (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=see_link\">",
"        \"Patient information: Uterine fibroids (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Pain clinics may be able to treat patients with severe and chronic pelvic pain without surgery. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"        \"Patient information: Chronic pelvic pain in women (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Endometrial ablation, in which a physician destroys or removes most of the endometrium using an instrument inserted through the vagina and cervix and into the uterus. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?22/35/23094?source=see_link\">",
"        \"Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Medical therapy using hormonal medications, such GnRH analogs (for example, leuprolide) or progestins can help reduce the pain associated with endometriosis. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?25/63/26611?source=see_link\">",
"        \"Patient information: Endometriosis (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Cone biopsy (eg, cold knife cone), cryosurgery, laser surgery, or loop electrocautery (eg, LEEP or LLETZ) are usually used to treat women with cervical dysplasia (an abnormal Pap smear). These procedures remove the abnormal part of the cervix rather than the entire cervix and uterus (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=see_link\">",
"        \"Patient information: Cervical cancer screening (Beyond the Basics)\"",
"       </a>",
"       ).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804579549\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1201710\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/41/3731?source=see_link\">",
"      Patient information: Hysterectomy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/1/11283?source=see_link\">",
"      Patient information: Ovarian cancer (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=see_link\">",
"      Patient information: Uterine cancer (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/8/5251?source=see_link\">",
"      Patient information: Endometriosis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/15/38129?source=see_link\">",
"      Patient information: Postpartum hemorrhage (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/18/12579?source=see_link\">",
"      Patient information: Preserving fertility after cancer treatment in women (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/13/25810?source=see_link\">",
"      Patient information: Uterine adenomyosis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1201760\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/35/23094?source=see_link\">",
"      Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=see_link\">",
"      Patient information: Uterine fibroids (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"      Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"      Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=see_link\">",
"      Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=see_link\">",
"      Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/34/41507?source=see_link\">",
"      Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/55/32627?source=see_link\">",
"      Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/63/12276?source=see_link\">",
"      Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/4/32835?source=see_link\">",
"      Patient information: Postmenopausal hormone therapy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/27/28083?source=see_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/48/34564?source=see_link\">",
"      Patient information: Vaginal hysterectomy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/63/26611?source=see_link\">",
"      Patient information: Endometriosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=see_link\">",
"      Patient information: Cervical cancer screening (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/46/32490?source=see_link\">",
"      Abdominal hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31866?source=see_link\">",
"      An overview of endometrial ablation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35480?source=see_link\">",
"      Dilation and curettage",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/53/32601?source=see_link\">",
"      Hysteroscopic myomectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/22/14698?source=see_link\">",
"      Laparoscopic approach to hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/24/16775?source=see_link\">",
"      Prolapsed uterine leiomyoma (fibroid)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12602?source=see_link\">",
"      Overview of hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9498?source=see_link\">",
"      Overview of hysteroscopy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29367?source=see_link\">",
"      Peripartum hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14730?source=see_link\">",
"      Radical hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35401?source=see_link\">",
"      Vaginal hysterectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/3/12346?source=see_link\">",
"      Abdominal myomectomy",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The American College of Obstetricians and Gynecologists",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.acog.org/\">",
"        www.acog.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       US Department of Health &amp; Human Services, Federal Government Source for Women's Health Information",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://womenshealth.gov/\">",
"        womenshealth.gov",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?6/16/6405/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?6/16/6405?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6405/abstract/1\">",
"      Meeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol 1997; 40:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6405/abstract/2\">",
"      Harris WJ. Complications of hysterectomy. Clin Obstet Gynecol 1997; 40:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6405/abstract/3\">",
"      Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol 1994; 83:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6405/abstract/4\">",
"      Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999; 282:1934.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f6_16_6405=[""].join("\n");
var outline_f6_16_6405=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ABDOMINAL HYSTERECTOMY OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           FEMALE ANATOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           REASONS FOR ABDOMINAL HYSTERECTOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           PRE-OPERATIVE PLANNING AND EVALUATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           ABDOMINAL HYSTERECTOMY PROCEDURE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           ABDOMINAL HYSTERECTOMY COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H26\">",
"           RECOVERY AFTER ABDOMINAL HYSTERECTOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H27\">",
"           LIFE AFTER ABDOMINAL HYSTERECTOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           ALTERNATIVES TO HYSTERECTOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/29/39391\" title=\"figure 1\">",
"           Abdom incisions PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/40/38534\" title=\"figure 2\">",
"           Abdominal hysterectomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\" title=\"figure 3\">",
"           Female anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?21/12/21707\" title=\"table 1\">",
"           Hysterectomy outcome PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f6_16_6406="Interferon alfacon-1 (consensus interferon): Patient drug information";
var content_f6_16_6406=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Interferon alfacon-1 (consensus interferon): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/15/24822?source=see_link\">",
"     see \"Interferon alfacon-1 (consensus interferon): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Infergen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Alpha interferons may cause or make diseases of the mind worse. Taking one's own life, ideas of killing yourself or murder, low mood (depression), forceful actions, hallucinations, psychoses, and relapse of drug addiction have happened with use. Alpha interferons may make infections worse, cause blood flow problems or some autoimmune diseases. If you think you have any of these health problems, call your doctor right away. Side effects such as low blood pressure, a fast heartbeat, and heart attacks have happened while taking alpha interferons. If you have very bad signs or if signs of these health problems get worse, talk with your doctor about stopping this drug. Problems are most often fixed after you stop the drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat long-term hepatitis C infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to interferon alfacon-1 or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698534",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) or high blood pressure, have an eye exam before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust during care and for 6 months after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy during care and for 6 months after care ends. Use birth control that you can trust.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain or bloody loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime to help with flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695949",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot is most often given 3 times a week for about 6 months.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694561",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Before giving the shot, bring it to room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to give closely if you or a family member is giving the shot at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw syringe away after use. Do not use more than one time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the next dose is less than 48 hours away, call your doctor to find out what to do.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10765 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-2D9DC08A38-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6406=[""].join("\n");
var outline_f6_16_6406=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183388\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027678\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027680\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027679\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027684\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027685\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027687\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027682\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027683\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027688\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027689\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/15/24822?source=related_link\">",
"      Interferon alfacon-1 (consensus interferon): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_16_6407="Oncocytic oxyphilic carcinoid";
var content_f6_16_6407=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Typical carcinoid tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of a typical pulmonary carcinoid tumor with oncocytic features and abundant oxyphilic tumor cell cytoplasm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6407=[""].join("\n");
var outline_f6_16_6407=null;
var title_f6_16_6408="Dissolution therapy for the treatment of gallstones";
var content_f6_16_6408=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dissolution therapy for the treatment of gallstones",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6408/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6408/contributors\">",
"     David Nunes, MD, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6408/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6408/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6408/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6408/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/16/6408/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role for the medical management of gallstone disease has decreased since the introduction of laparoscopic cholecystectomy. Cholecystectomy remains the preferred method because of its reduced cost, definitive nature, safety, and increased convenience for the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Furthermore, medical therapy of gallstones has been hampered by the high incidence of recurrent stones. As a result, interest in nonsurgical techniques for the management of gallstones has waned significantly.",
"   </p>",
"   <p>",
"    Nevertheless, medical management using dissolution therapy may be an alternative to cholecystectomy in selected patients with symptomatic gallstone disease with a view either to eliminating stones or reducing the risk of further complications. In the past, the nonsurgical treatment of gallstones also included extracorporeal shock wave lithotripsy, though this is now rarely done. Successful treatment depends upon a functioning gallbladder and varies based upon the number, size, and composition of the stone(s). As a result, many symptomatic patients have stones that are not ideally suited to dissolution therapy, producing less than optimal results. The primary candidates for elective nonsurgical management of gallstones are patients who are symptomatic or are at high risk for developing symptomatic gallstone disease, but are not candidates for surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14582?source=see_link\">",
"     \"Patient selection for the nonsurgical treatment of gallstone disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with acute gallstone-related disease who are not surgical candidates may require percutaneous cholecystostomy. Case series have also described placement of a cystic duct stent during endoscopic retrograde cholangiopancreatography in patients with gallstone-related disease (such as biliary colic, acute cholecystitis, acalculous cholecystitis, and gallstone pancreatitis) and serious comorbidities that precluded other approaches [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. Although placement of such stents may be technically challenging, they can provide sufficient palliation until more definitive therapy can be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6742?source=see_link\">",
"     \"Acalculous cholecystitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=see_link\">",
"     \"Treatment of acute cholecystitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review dissolution therapy for the elective treatment of gallstones. Endoscopic sphincterotomy for gallstone-related disease without subsequent cholecystectomy, the selection of patients for nonsurgical treatment of gallstones, and laparoscopic cholecystectomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=see_link\">",
"     \"Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14582?source=see_link\">",
"     \"Patient selection for the nonsurgical treatment of gallstone disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=see_link\">",
"     \"Laparoscopic cholecystectomy: Techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPOSITION OF GALLSTONES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most medical therapies have been developed for the management of cholesterol-rich gallstones. Gallstones are composed of a mixture of cholesterol, calcium bilirubinate, proteins, and mucin. They are broadly classified as cholesterol, black pigment, or brown pigment stones, depending upon the predominant constituents, although most \"cholesterol\" stones have a mixed composition with small amounts of calcium and bilirubin salts. Black pigment stones result from hemolysis and consist primarily of calcium bilirubinate. Brown pigment stones are associated with bacterial and helminthic infection of the biliary system and are most commonly seen in Asia. They may also occur as de novo common bile duct stones following cholecystectomy.",
"   </p>",
"   <p>",
"    The prevalence of pigment stones is dependent primarily upon the frequency of hemolytic disorders in the community. In industrialized countries, cholesterol gallstones account for about 75 percent of stones, black pigment stones for 20 percent, and brown pigment stones for 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/9-13\">",
"     9-13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MEDICAL GALLSTONE DISSOLUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallstone dissolution therapy is comprised primarily of bile salt dissolution using orally administered medications. Contact dissolution therapy is seldom, if ever, used.",
"   </p>",
"   <p>",
"    The success of medical management depends upon the size and composition of the gallstone(s) and gallbladder function. Small, cholesterol-rich stones without evidence of calcification and low concentrations of bilirubin salts are the best candidates for bile acid therapy. In the past, larger stones were sometimes treated with lithotripsy combined with oral bile salts to facilitate dissolution and clearance through fragmentation of the stone(s). However, both lithotripsy and contact dissolution therapy are no longer used for the management of gallbladder stones. Patients with calcified and pigment stones are generally poor candidates for medical therapy.",
"   </p>",
"   <p>",
"    Good gallbladder function is necessary to clear stone debris and to minimize the risk of stone recurrence. Appropriate patient selection is of paramount importance, although even carefully selected patients have significant failure rates [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14582?source=see_link\">",
"     \"Patient selection for the nonsurgical treatment of gallstone disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bile acid therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrophilic bile acids, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33076?source=see_link\">",
"     chenodeoxycholic acid",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     ursodeoxycholic acid",
"    </a>",
"    (UDCA), have been used in the treatment of cholesterol gallstones, though only UDCA is currently used because chenodeoxycholic acid is associated with a number of adverse side effects. Bile acids work by reducing biliary cholesterol secretion, increasing biliary bile acid concentrations, and as a result, reducing the cholesterol saturation index. UDCA has been shown to inhibit biliary secretion of cholesterol, reduce intestinal absorption of cholesterol, increase hepatic bile secretion, and improve gallbladder emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/16-21\">",
"     16-21",
"    </a>",
"    ]. Bile acids have also been shown to improve gallbladder muscle contractility and reduce gallbladder wall inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/17\">",
"     17",
"    </a>",
"    ]. All pure cholesterol stones would be expected to dissolve in bile that is unsaturated with cholesterol. However, most gallstones have a mixed composition, containing significant amounts of calcium salts, which limits the efficacy of this form of therapy. Occasionally, rim calcification develops, inhibiting further stone dissolution.",
"   </p>",
"   <p>",
"    Patients selected for oral bile acid therapy should have the following favorable characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/14,16,22,23\">",
"     14,16,22,23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Small stone size (&lt;0.5 to 1 cm)",
"     </li>",
"     <li>",
"      Mild symptoms",
"     </li>",
"     <li>",
"      Good gallbladder function (ie, normal filling and emptying)",
"     </li>",
"     <li>",
"      Minimal calcification and low density on computed tomographic (CT) imaging",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The primary aim of therapy should be to achieve complete gallstone dissolution. Secondary goals include a reduction in the severity of symptoms and risk of complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H66996275\">",
"    <span class=\"h3\">",
"     Choice of bile acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early studies showed that 40 to 60 percent of carefully selected patients treated with 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33076?source=see_link\">",
"     chenodeoxycholic acid",
"    </a>",
"    cleared their gallstones after 12 to 24 months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. However, dose-related diarrhea is seen in approximately 50 percent of patients, significantly limiting the acceptability of chenodeoxycholic acid monotherapy. Furthermore, hypercholesterolemia and increased serum aminotransferases are observed in a substantial proportion of patients.",
"   </p>",
"   <p>",
"    UDCA has significantly fewer side effects than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33076?source=see_link\">",
"     chenodeoxycholic acid",
"    </a>",
"    , causes less diarrhea, does not increase serum cholesterol, and has no hepatotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/26\">",
"     26",
"    </a>",
"    ]. It is the bile acid typically chosen for dissolution therapy. The only drawback to UDCA is its cost.",
"   </p>",
"   <p>",
"    Combining these two agents using lower doses of each has been used to offset the side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33076?source=see_link\">",
"     chenodeoxycholic acid",
"    </a>",
"    and the high cost of UDCA. Some studies suggest that this combination may be superior to the use of either agent alone, but others have not confirmed these results [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/27-30\">",
"     27-30",
"    </a>",
"    ], and as a result, this approach is not generally used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H66996528\">",
"    <span class=\"h3\">",
"     Dosing and rate of dissolution",
"    </span>",
"    &nbsp;&mdash;&nbsp;UDCA is typically given as a dose of 10 to 14",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/31\">",
"     31",
"    </a>",
"    ]. It is suggested that bile acids be given at bedtime to maintain hepatic bile acid secretion overnight. This reduces secretion of supersaturated bile and increases stone dissolution rates [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. The rate of gallstone dissolution in patients taking UDCA at a standard dose is about 1 mm per month [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H66996555\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of oral dissolution therapy correlate with the size and composition of the gallstones and the rigor with which the patients have been selected. Studies using strict inclusion criteria have found dissolution rates of between 50 to 60 percent, and a meta-analysis found a 37 percent dissolution rate with UDCA, with the best results occurring in patients with small, buoyant stones [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If only ideal patients are selected (those with small, noncalcified, buoyant stones), dissolution rates may exceed 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/25\">",
"     25",
"    </a>",
"    ]. Unfortunately, less than 10 percent of patients fall into this category. The response to treatment is slow, with gallstone size falling by only 1",
"    <span class=\"nowrap\">",
"     mm/month",
"    </span>",
"    on average. Thus, treatment may be required for two years or more.",
"   </p>",
"   <p>",
"    Incomplete dissolution remains a significant problem. This has been attributed to insoluble components of the gallstones as well as a process referred to as \"rim calcification,\" in which calcium is laid down upon the surface of the stone. Rim calcification has been reported in 10 to 12 percent of patients treated with bile acids [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Rim calcification was initially thought to be associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     ursodeoxycholic acid",
"    </a>",
"    therapy, but it has also been found using other bile salts [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/35\">",
"     35",
"    </a>",
"    ]. High calcium content of the stone may facilitate rim calcification. Careful selection of non-calcium-containing stones using CT scan may prevent some of these therapeutic failures. As expected, patients with low-density stones on a CT scan (&lt;75 Hounsfield units) respond more rapidly and completely to oral bile acid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, several studies have suggested that treatment with bile acids prevents gallstone-related symptoms, even in patients in whom gallstone dissolution is incomplete [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/22,26,30,39\">",
"     22,26,30,39",
"    </a>",
"    ]. This observation was supported by a cohort study that included 527 patients with gallstones who were followed for up to 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/22\">",
"     22",
"    </a>",
"    ]. The patients received UDCA (600",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or no specific treatment based upon their preference. Multivariate analysis showed that UDCA was associated with a significantly reduced risk of gallstone-related symptoms at up to 10 years of follow-up (62 versus 92 percent in those with a history of gallstone-related symptoms, and 6 versus 12 percent in those without a prior history of symptoms). This benefit was independent of stone dissolution.",
"   </p>",
"   <p>",
"    Although this study is limited by its nonrandomized design, it suggests a potential benefit of long-term bile acid therapy in symptomatic patients in whom cholecystectomy is undesirable, even if complete gallstone dissolution cannot be accomplished. However, randomized trials are required to confirm these findings.",
"   </p>",
"   <p>",
"    On the other hand, a short course of therapy may not be of benefit. This issue arises in regions where there is a long waiting time between the diagnosis of gallstone disease and subsequent cholecystectomy. The role of UDCA in this setting was evaluated in a trial of 177 symptomatic patients with gallstones who were randomly assigned to UDCA or placebo while awaiting cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/40\">",
"     40",
"    </a>",
"    ]. No significant difference was observed in the proportion of patients with gallstone-related symptoms during an average follow-up of about 90 days. While the study may have been too small to detect a difference, it suggests that a benefit of UDCA in preventing gallstone symptoms in the short-term is small at best.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H66996686\">",
"    <span class=\"h3\">",
"     Gallstone recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a significant incidence of stone recurrence following bile acid treatment. Approximately 15 percent of patients will recur by one year, and 45 percent will recur by five years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/41-46\">",
"     41-46",
"    </a>",
"    ]. The risk appears to be highest in those with multiple stones and in whom the time to complete dissolution was longest [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Statins",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been interest in the use of HMG CoA reductase inhibitors (statins) in the treatment of cholesterol gallstone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. These agents reduce biliary cholesterol secretion, providing the rationale for their use in gallstone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/49\">",
"     49",
"    </a>",
"    ]. However, they do not alter the cholesterol saturation index, probably because of a concomitant reduction in bile acid and phospholipid secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/47,50\">",
"     47,50",
"    </a>",
"    ]. Two studies from the US and UK suggested that long-term use of statins is associated with a modest reduction in the need for cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies suggest that statins lead to gallstone dissolution or prevent the formation of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/48,51-57\">",
"     48,51-57",
"    </a>",
"    ], whereas others do not [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/50,58-61\">",
"     50,58-61",
"    </a>",
"    ]. Combining statins with bile acids has also been studied with mixed results [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/58,62\">",
"     58,62",
"    </a>",
"    ]. As an example, in a randomized controlled trial, 50 patients with radiolucent gallstones were treated with UDCA (600",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or UDCA (600",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    for 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/62\">",
"     62",
"    </a>",
"    ]. At the end of the study, significantly more patients with multiple gallstones who received simvastatin and UDCA achieved dissolution compared with those who received UDCA alone (71 versus 25 percent). However, combined therapy was not significantly better than UDCA alone in patients who had single gallstones.",
"   </p>",
"   <p>",
"    Based upon the available data, there is insufficient evidence to recommend the use of statins for the treatment or prevention of gallstones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H66996958\">",
"    <span class=\"h2\">",
"     Ezetimibe",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/42/4773?source=see_link\">",
"     Ezetimibe",
"    </a>",
"    is a hypocholesterolemic drug that acts by inhibiting intestinal cholesterol absorption. Animal models suggest that it may be effective for the treatment or prevention of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. It lowers biliary cholesterol secretion but does not decrease the bile salt content in bile. In humans it has been shown reduce the cholesterol saturation index of bile and retarded cholesterol crystallization [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/63\">",
"     63",
"    </a>",
"    ]. Trials are needed in humans to determine if it is effective for gallstone prevention or dissolution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Monoterpenes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rowachol, an orally administered mixture of cyclic monoterpenes, has been used in several studies for the dissolution of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. This agent is capable of dissolving radiolucent and some radio-opaque gallstones. Furthermore, it also enhanced the efficacy of UDCA or lithotripsy when these modalities were used in combination. However, the added benefit is modest, and these agents are not widely used, although they are available through alternative medicine outlets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Contact dissolution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contact dissolution of gallstones with solvents instilled directly into the gallbladder was another approach to treating gallstones without surgery that is no longer performed. While results with this technique were good, with up to 92 percent of patients with radiolucent stones achieving complete stone dissolution [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/67-69\">",
"     67-69",
"    </a>",
"    ], the procedure was technically complex, had potentially significant side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/70-72\">",
"     70-72",
"    </a>",
"    ], and was associated with high rates of stone recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6408/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. In addition, the most widely used solvent, methyl tert-butyl ether (MTBE), is no longer available due to concerns regarding toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/29/8658?source=see_link\">",
"       \"Patient information: Gallstones (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/56/1923?source=see_link\">",
"       \"Patient information: Gallbladder removal (cholecystectomy) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/21/7507?source=see_link\">",
"       \"Patient information: Gallstones (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic gallstones are uncommonly treated with medical therapy alone. The main form of medical therapy is the bile acid",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"       ursodeoxycholic acid",
"      </a>",
"      (UDCA), which may enhance gallstone dissolution and perhaps reduce symptoms in patients with mild symptoms or those who are not candidates for laparoscopic surgery. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bile acid therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest dissolution therapy with UDCA in patients with mild symptoms who have poorly calcified small stone(s) and are not candidates for laparoscopic cholecystectomy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bile acid therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The success of these techniques varies from 40 to 90 percent depending upon patient compliance, the stone characteristics, gallbladder function, and the experience of the center. Gallstone recurrence remains a significant problem, although only a small proportion of patients develop recurrent symptoms, at least in the short-term. Long-term bile acid therapy should be considered in patients who would not tolerate complicated stone recurrence and who are not surgical candidates.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/1\">",
"      Darzi A, Geraghty JG, Williams NN, et al. The pros and cons of laparoscopic cholecystectomy and extracorporeal shock wave lithotripsy in the management of gallstone disease. Ann R Coll Surg Engl 1994; 76:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/2\">",
"      Portincasa P, van de Meeberg P, van Erpecum KJ, et al. An update on the pathogenesis and treatment of cholesterol gallstones. Scand J Gastroenterol Suppl 1997; 223:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/3\">",
"      Conway JD, Russo MW, Shrestha R. Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc 2005; 61:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/4\">",
"      Shrestha R, Trouillot TE, Everson GT. Endoscopic stenting of the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease awaiting orthotopic liver transplantation. Liver Transpl Surg 1999; 5:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/5\">",
"      Shrestha R, Bilir BM, Everson GT, Steinberg SE. Endoscopic stenting of gallbladder for symptomatic cholelithiasis in patients with end-stage liver disease awaiting orthotopic liver transplantation. Am J Gastroenterol 1996; 91:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/6\">",
"      Gaglio PJ, Buniak B, Leevy CB. Primary endoscopic retrograde cholecystoendoprosthesis: a nonsurgical modality for symptomatic cholelithiasis in cirrhotic patients. Gastrointest Endosc 1996; 44:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/7\">",
"      Kalloo AN, Thuluvath PJ, Pasricha PJ. Treatment of high-risk patients with symptomatic cholelithiasis by endoscopic gallbladder stenting. Gastrointest Endosc 1994; 40:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/8\">",
"      Schlenker C, Trotter JF, Shah RJ, et al. Endoscopic gallbladder stent placement for treatment of symptomatic cholelithiasis in patients with end-stage liver disease. Am J Gastroenterol 2006; 101:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/9\">",
"      Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/10\">",
"      Attili AF, Carulli N, Roda E, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol 1995; 141:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/11\">",
"      Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997; 26:809.",
"     </a>",
"    </li>",
"    <li>",
"     Sherlock S, Dooley J. Diseases of the liver and biliary system, Blackwell Science, Oxford 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/13\">",
"      Trotman BW, Soloway RD. Pigment vs cholesterol cholelithiasis: clinical and epidemiological aspects. Am J Dig Dis 1975; 20:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/14\">",
"      Fromm H, Malavolti M. Bile acid dissolution therapy of gallbladder stones. Baillieres Clin Gastroenterol 1992; 6:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/15\">",
"      Peine CJ. Gallstone-dissolving agents. Gastroenterol Clin North Am 1992; 21:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/16\">",
"      Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994; 121:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/17\">",
"      Guarino MP, Cong P, Cicala M, et al. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 2007; 56:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/18\">",
"      Hardison WG, Grundy SM. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 1984; 87:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/19\">",
"      Uchida K, Akiyoshi T, Igimi H, et al. Differential effects of ursodeoxycholic acid and ursocholic acid on the formation of biliary cholesterol crystals in mice. Lipids 1991; 26:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/20\">",
"      Wang DQ, Tazuma S, Cohen DE, Carey MC. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am J Physiol Gastrointest Liver Physiol 2003; 285:G494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/21\">",
"      van de Heijning BJ, van de Meeberg PC, Portincasa P, et al. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 1999; 44:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/22\">",
"      Tomida S, Abei M, Yamaguchi T, et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999; 30:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/23\">",
"      Paumgartner G, Pauletzki J, Sackmann M. Ursodeoxycholic acid treatment of cholesterol gallstone disease. Scand J Gastroenterol Suppl 1994; 204:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/24\">",
"      Tangedahl T, Carey WD, Ferguson DR, et al. Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk. Dig Dis Sci 1983; 28:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/25\">",
"      Maton PN, Iser JH, Reuben A, et al. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine (Baltimore) 1982; 61:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/26\">",
"      Tint GS, Salen G, Colalillo A, et al. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med 1982; 97:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/27\">",
"      Tudyka J, Kratzer W, Janowitz P, et al. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy. Am J Gastroenterol 1995; 90:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/28\">",
"      May GR, Sutherland LR, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther 1993; 7:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/29\">",
"      Jazrawi RP, Pigozzi MG, Galatola G, et al. Optimum bile acid treatment for rapid gall stone dissolution. Gut 1992; 33:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/30\">",
"      Petroni ML, Jazrawi RP, Pazzi P, et al. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group. Aliment Pharmacol Ther 2001; 15:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/31\">",
"      Di Ciaula A, Wang DQ, Wang HH, et al. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am 2010; 39:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/32\">",
"      Kupfer RM, Maudgal DP, Northfield TC. Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig Dis Sci 1982; 27:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/33\">",
"      Lanzini A, Facchinetti D, Northfield TC. Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration. Gastroenterology 1988; 95:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/34\">",
"      Senior JR, Johnson MF, DeTurck DM, et al. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids. Gastroenterology 1990; 99:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/35\">",
"      Bazzoli F, Festi D, Mazzella G, et al. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids. Am J Gastroenterol 1995; 90:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/36\">",
"      Bateson MC, Bouchier IA, Trash DB, et al. Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid. Br Med J (Clin Res Ed) 1981; 283:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/37\">",
"      Walters JR, Hood KA, Gleeson D, et al. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy. Gut 1992; 33:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/38\">",
"      Pereira SP, Veysey MJ, Kennedy C, et al. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse. Dig Dis Sci 1997; 42:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/39\">",
"      Frigerio G. Ursodeoxycholic acid in the treatment of dyspepsia; Report of a multicenter controlled trial. Curr Ther Res 1979; 26:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/40\">",
"      Venneman NG, Besselink MG, Keulemans YC, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006; 43:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/41\">",
"      Petroni ML, Jazrawi RP, Pazzi P, et al. Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group. Eur J Gastroenterol Hepatol 2000; 12:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/42\">",
"      Portincasa P, van Erpecum KJ, van De Meeberg PC, et al. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996; 24:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/43\">",
"      Lanzini A, Jazrawi RP, Kupfer RM, et al. Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 1986; 3:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/44\">",
"      Rabenstein T, Radespiel-Tr&ouml;ger M, H&ouml;pfner L, et al. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Eur J Gastroenterol Hepatol 2005; 17:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/45\">",
"      Sackmann M, Ippisch E, Sauerbruch T, et al. Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990; 98:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/46\">",
"      Villanova N, Bazzoli F, Taroni F, et al. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 1989; 97:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/47\">",
"      Saunders KD, Cates JA, Abedin MZ, Roslyn JJ. Lovastatin and gallstone dissolution: a preliminary study. Surgery 1993; 113:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/48\">",
"      Chapman BA, Burt MJ, Chisholm RJ, et al. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor. Dig Dis Sci 1998; 43:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/49\">",
"      Kallien G, Lange K, Stange EF, Scheibner J. The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans. Hepatology 1999; 30:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/50\">",
"      Smit JW, van Erpecum KJ, Renooij W, et al. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 1995; 21:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/51\">",
"      Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Statin use and the risk of cholecystectomy in women. Gastroenterology 2009; 136:1593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/52\">",
"      Bodmer M, Brauchli YB, Kr&auml;henb&uuml;hl S, et al. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 2009; 302:2001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/53\">",
"      Gonz&aacute;lez-P&eacute;rez A, Garc&iacute;a Rodr&iacute;guez LA. Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf 2007; 16:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/54\">",
"      Porsch-Oz&ccedil;&uuml;r&uuml;mez M, Hardt PD, Schnell-Kretschmer H, et al. Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation index. Eur J Clin Pharmacol 2001; 56:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/55\">",
"      Smith JL, Roach PD, Wittenberg LN, et al. Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones. J Gastroenterol Hepatol 2000; 15:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/56\">",
"      Wilson IR, Hurrell MA, Pattinson NR, Chapman BA. The effect of simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulin-dependent diabetics. J Gastroenterol Hepatol 1994; 9:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/57\">",
"      Erichsen R, Fr&oslash;slev T, Lash TL, et al. Long-term statin use and the risk of gallstone disease: A population-based case-control study. Am J Epidemiol 2011; 173:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/58\">",
"      Sackmann M, Koelbl R, Pauletzki J, et al. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy. Z Gastroenterol 1995; 33:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/59\">",
"      Caroli-Bosc FX, Le Gall P, Pugliese P, et al. Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population. Dig Dis Sci 2001; 46:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/60\">",
"      Miettinen TE, Kiviluoto T, Taavitsainen M, et al. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 1998; 27:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/61\">",
"      Sharma BC, Agarwal DK, Baijal SS, Saraswat VA. Pravastatin has no effect on bile lipid composition, nucleation time, and gallbladder motility in persons with normal levels of cholesterol. J Clin Gastroenterol 1997; 25:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/62\">",
"      Tazuma S, Kajiyama G, Mizuno T, et al. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. J Clin Gastroenterol 1998; 26:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/63\">",
"      Wang HH, Portincasa P, Mendez-Sanchez N, et al. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008; 134:2101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/64\">",
"      Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, et al. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 2008; 12:2097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/65\">",
"      Doran J, Keighley MR, Bell GD. Rowachol--a possible treatment for cholesterol gallstones. Gut 1979; 20:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/66\">",
"      Ellis WR, Somerville KW, Whitten BH, Bell GD. Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) 1984; 289:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/67\">",
"      Feretis CB, Malas EG, Mansouras AJ, et al. Endoscopic transpapillary catheterization of the gallbladder followed by external shock wave lithotripsy and solvent infusion for the treatment of gallstone disease. Gastrointest Endosc 1992; 38:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/68\">",
"      Holl J, Sauerbruch T, Sackmann M, et al. Combined treatment of symptomatic gallbladder stones by extracorporeal shock-wave lithotripsy (ESWL) and instillation of methyl tert-butyl ether (MTBE). Dig Dis Sci 1991; 36:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/69\">",
"      Darzi A, Monson JR, Keeling PW, et al. Combined ultrasound-guided extracorporeal shockwave lithotripsy and MTBE instillation in the treatment of common bile duct stones. Hepatogastroenterology 1991; 38:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/70\">",
"      vanSonnenberg E, Zakko S, Hofmann AF, et al. Human gallbladder morphology after gallstone dissolution with methyl tert-butyl ether. Gastroenterology 1991; 100:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/71\">",
"      Esch O, Spinosa JC, Hamilton RL, et al. Acute effects of topical methyl tert-butyl ether or ethyl propionate on gallbladder histology in animals: a comparison of two solvents for contact dissolution of cholesterol gallstones. Hepatology 1992; 16:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/72\">",
"      Adam G, Knuechel R, Vorwerk D, et al. Tissue response of the biliary and digestive system of rabbits after MTBE infusion into the gallbladder. Invest Radiol 1990; 25:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/73\">",
"      Thistle JL, May GR, Bender CE, et al. Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med 1989; 320:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6408/abstract/74\">",
"      Pauletzki J, Holl J, Sackmann M, et al. Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether. Dig Dis Sci 1995; 40:1775.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 670 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-6720EAAD2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6408=[""].join("\n");
var outline_f6_16_6408=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPOSITION OF GALLSTONES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MEDICAL GALLSTONE DISSOLUTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bile acid therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H66996275\">",
"      - Choice of bile acid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H66996528\">",
"      - Dosing and rate of dissolution",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H66996555\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H66996686\">",
"      - Gallstone recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Statins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H66996958\">",
"      Ezetimibe",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Monoterpenes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Contact dissolution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6742?source=related_link\">",
"      Acalculous cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=related_link\">",
"      Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=related_link\">",
"      Laparoscopic cholecystectomy: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/56/1923?source=related_link\">",
"      Patient information: Gallbladder removal (cholecystectomy) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/21/7507?source=related_link\">",
"      Patient information: Gallstones (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/29/8658?source=related_link\">",
"      Patient information: Gallstones (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14582?source=related_link\">",
"      Patient selection for the nonsurgical treatment of gallstone disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=related_link\">",
"      Treatment of acute cholecystitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_16_6409="Normal reading development and etiology of reading difficulty in children";
var content_f6_16_6409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Normal reading development and etiology of reading difficulty in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6409/contributors\">",
"     S Sutton Hamilton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6409/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/16/6409/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading is critical to the academic, economic, and social success of children. However, many children complete schooling without achieving more than basic literacy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/1\">",
"     1",
"    </a>",
"    ]. Reading achievement has consistently been a robust predictor of future antisocial behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/2\">",
"     2",
"    </a>",
"    ]. Children with reading difficulties are considerably less likely to graduate high school, and thus are at greater risk for unemployment, underemployment, and incarceration [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric clinicians are well positioned to identify children at risk for reading difficulties and children who have unexpected difficulties in learning to read. Early identification and timely intervention for such children improves long-term outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17592?source=see_link\">",
"     \"Interventions for children with reading difficulty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology, etiology, and pathogenesis of reading difficulty in children will be reviewed here. The clinical evaluation, diagnosis, and treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1370?source=see_link\">",
"     \"Clinical features and evaluation of reading difficulty in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17592?source=see_link\">",
"     \"Interventions for children with reading difficulty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    General issues related to learning disabilities also are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=see_link\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=see_link\">",
"     \"Specific learning disabilities in children: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37306?source=see_link\">",
"     \"Specific learning disabilities in children: Educational management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL READING DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Literacy development is a process that begins in infancy and has a natural hierarchy of progression. Literacy develops in parallel with language, but in contrast to language, which is natural and inherent, reading is acquired and must be taught (",
"    <a class=\"graphic graphic_table graphicRef72624 \" href=\"UTD.htm?35/25/36253\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/22/10599?source=see_link\">",
"     \"Emergent literacy including language development\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The transition from prereading to reading skills usually begins when children enter school [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/5\">",
"     5",
"    </a>",
"    ]. At this stage, children begin to associate written letters with sounds. They gradually learn to recognize all of the letters within a word and to map the letters onto the correct sound. With repeated exposure, and reading words in context, children are able to recognize certain words automatically.",
"   </p>",
"   <p>",
"    The skills needed for normal reading encompass five domains [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Phonemic awareness &ndash; Ability to focus on and manipulate phonemes (the smallest units of spoken language) in spoken words.",
"     </li>",
"     <li>",
"      Phonics &ndash; Knowledge of relationships between letters and sounds and spelling-sound correspondence, which allows decoding of words. The English language is particularly difficult for beginning readers because it contains inconsistent mappings between letters and sounds [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sight word acquisition &ndash; Automaticity of reading words by sight without having to decode sound by sound; sight word acquisition facilitates reading efficiency.",
"     </li>",
"     <li>",
"      Vocabulary &ndash; The knowledge of word meanings.",
"     </li>",
"     <li>",
"      Comprehension &ndash; The ability to think about and extract the information provided in text while reading. Reading comprehension is influenced by the ability to decode and sight read, vocabulary, oral comprehension, and &ldquo;executive function&rdquo; (eg, higher order skills such as working memory and planning) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/5,10\">",
"       5,10",
"      </a>",
"      ]. When reading passages, children construct meaning from sentences, which they must remember as reading progresses; at the same time they must link the information that is read to their background knowledge to anticipate what comes next [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The &ldquo;simple view of reading&rdquo; conceptualizes reading as two-step process: the first involves decoding, in which written letters are translated into words; the second involves extracting meaning from words. Extracting meaning from words draws on the same skills required to understand spoken language &mdash; vocabulary, knowledge of grammatical structure, and the ability to make inference. Although reading is predominantly the product of word identification and reading comprehension, other factors such as rapid word identification and reading fluency play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TERMINOLOGY AND CONCEPTUAL FRAMEWORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of terms are used to describe reading problems. Different terms may be used in different settings and by different groups (eg, educators, health care providers). Definitions for the terms that are used in this topic review are provided below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Reading difficulty",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Reading difficulty\" is defined from a normative perspective (ie, how a child performs in reading compared to peers or educational expectations) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/12\">",
"     12",
"    </a>",
"    ]. Reading difficulty has a number of causes, the two most important of which are reading disability (ie, difficulties in decoding) and deficits in reading comprehension. The relationship between decoding deficits and reading comprehension deficits is unclear; they are currently considered to be separate deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/13\">",
"     13",
"    </a>",
"    ]. Most children with reading difficulties have some degree of deficit in both decoding and reading comprehension. However, some children have isolated deficiencies in either decoding or reading comprehension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other causes of reading difficulty include environmental factors (eg, lack of exposure to books or reading, inadequate instruction), cognitive impairment, hearing impairment, language impairment, chronic illness, and psychosocial stressors [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=see_link&amp;anchor=H19#H19\">",
"     \"Specific learning disabilities in children: Clinical features\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Reading disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading disability is best defined as \"an unexpected difficulty in learning how to read despite adequate intelligence, instruction, and motivation\" [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/12\">",
"     12",
"    </a>",
"    ]. The terms \"dyslexia\", \"developmental dyslexia\", \"specific reading disability\", and \"reading disorder\" are also used to describe this condition, although a more specific definition for \"dyslexia\" is provided below [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/17\">",
"     17",
"    </a>",
"    ]. Reading disability is the most common form of learning disability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=see_link\">",
"     \"Specific learning disabilities in children: Clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Dimensional model",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading ability and reading disability occur along a continuum; reading disabilities are present in degrees, like obesity or hypertension, rather than being present or absent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. Children with reading disabilities represent the tail end of a normal distribution of reading abilities [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Discrepancy model",
"    </span>",
"    &nbsp;&mdash;&nbsp;In practice, reading disability has been defined by reading skills that are 1.5 or more standard deviations (SD) below the intelligence quotient (IQ). This definition has been used for research purposes, and many states use it to determine whether a child qualifies for special education services [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, definitions based upon IQ-achievement discrepancy are problematic for several reasons and have largely been replaced by dimensional models. Problems with discrepancy models include [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,9,19-23\">",
"     4,9,19-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An arbitrarily defined cut-off. Children on one side of the cut-off do not differ in any qualitative way from those on the other side.",
"     </li>",
"     <li>",
"      Children with a similar level of reading difficulty share the same fundamental deficits and respond to the same interventions (regardless of IQ).",
"     </li>",
"     <li>",
"      Discrepancy definitions do not take into account the changing demands of reading over time.",
"     </li>",
"     <li>",
"      Because most intelligence tests contain items that depend upon knowledge and skills that are acquired through reading, they may underestimate intelligence in children with long-standing reading difficulties (and fail to identify them as reading disabled by the discrepancy definition).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Dyslexia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"dyslexia\" is used as a synonym for a specific reading disability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/9,24\">",
"     9,24",
"    </a>",
"    ]. The International Dyslexia Association defines dyslexia as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    \"Dyslexia is a specific learning disability that is neurological in origin. It is characterized by difficulties with accurate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fluent word recognition and by poor spelling and decoding abilities. These difficulties typically result from a deficit in the phonologic component of language that is often unexpected in relation to other cognitive abilities and the provision of effective classroom instruction. Secondary consequences may include problems in reading comprehension and reduced reading experience that can impede the growth of vocabulary and background knowledge.\"",
"   </p>",
"   <p>",
"    This definition has been adopted by the United States National Institutes of Child Health and Human Development and is similar to the definition proposed for the Diagnostic and Statistical Manual of Mental Disorders, Fifth edition (DSM-5) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/13\">",
"     13",
"    </a>",
"    ]. Proposed revisions for DSM-5 limit dyslexia to deficits in phonological awareness (ie, decoding); deficits in reading comprehension are excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the text that follows, \"reading disability\" is used synonymously with \"dyslexia\". Reading comprehension deficits are considered to be separate category of reading difficulty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H539446524\">",
"    <span class=\"h2\">",
"     Reading comprehension deficit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading comprehension deficit refers to difficulty in deriving meaning from written text that cannot be fully explained by difficulties in decoding (ie, reading",
"    <span class=\"nowrap\">",
"     disability/dyslexia)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/13\">",
"     13",
"    </a>",
"    ]. Reading comprehension problems are an important cause of persistent reading problems and may be related to underlying language disorders or problems with executive functions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/22,27\">",
"     22,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to decoding skills, reading comprehension skills are dimensional. Children with reading comprehension deficits represent the lower end of a normally distributed range of reading comprehension skills [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Dimensional model'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Reading difficulties",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 20 percent of children have significant difficulty learning to read [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/16\">",
"     16",
"    </a>",
"    ]. According to the National Assessment of Educational Progress, approximately 30 percent of United States fourth graders read below a basic proficiency level [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reading below the basic proficiency level is more common in boys than in girls in the United States (38 versus 31 percent among fourth graders and 32 versus 23 percent among eight graders in 2007) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/28\">",
"     28",
"    </a>",
"    ]. They are also substantially more common in minority children and children from low-income families [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/1,28\">",
"     1,28",
"    </a>",
"    ]. The exact cause of these discrepancies is not known, but low parental literacy, inadequate instruction, and other social risk factors are all thought to play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Reading disabilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading disability is the most common learning disability, accounting for approximately 80 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/29\">",
"     29",
"    </a>",
"    ]. In the United States, the reported prevalence of reading disability ranges from 5 to 17.5 percent of school children, depending upon the definition [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Reading disability is more commonly diagnosed in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/17,28\">",
"     17,28",
"    </a>",
"    ]. However, this probably reflects a referral bias [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for reading difficulty include [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/24\">",
"     24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A family history of language, speech, or reading difficulties [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/36-38\">",
"       36-38",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Genetics'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A personal history of speech and language impairment in preschool (more strongly associated with reading comprehension than phonologic deficits) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/22,27,39\">",
"       22,27,39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1370?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features and evaluation of reading difficulty in children\", section on 'Preschooler at risk'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 50 percent of children with a history of speech and language impairment develop a reading disability during the early school years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/27\">",
"     27",
"    </a>",
"    ]. Children receiving intervention (eg, speech and language therapy, Head Start programs) for identified risk factors remain at a higher risk of reading difficulties than other children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/22,40\">",
"     22,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, children with a history of prematurity and low birth weight are at increased risk for reading and other learning disabilities [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Environmental risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environmental risk factors for reading difficulty include [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lack of exposure to books and reading",
"     </li>",
"     <li>",
"      Lack of instruction in prereading skills",
"     </li>",
"     <li>",
"      Poverty",
"     </li>",
"     <li>",
"      Low parental education",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although such factors may be present in children with reading disability, they are not the fundamental problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND PATHOGENESIS OF READING DISABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major problem in children with reading disability is thought to be a deficit in phonologic processing [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/8,9,24,42,43\">",
"     8,9,24,42,43",
"    </a>",
"    ]. Deficits in executive function (eg, short-term memory) may contribute to problems in reading comprehension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/10\">",
"     10",
"    </a>",
"    ]. Twin, molecular linkage, neuroanatomic, and neurophysiologic studies indicate that reading disability is a heritable trait with a neurobiologic basis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/26,44-51\">",
"     26,44-51",
"    </a>",
"    ]. The exact mechanisms through which genetic and neuroanatomic factors affect phonologic processing are not entirely clear, but are beginning to be elucidated with functional brain imaging studies.",
"   </p>",
"   <p>",
"    Reading disability is not a vision problem. Children with reading disability do not see letters and words in reverse; nor do they have inherent spatial deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Phonologic deficit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before learning to read, a child must understand that spoken words can be broken down into smaller units of sound (ie, phonemes) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. As an example, the word \"cat\" consists of the phonemes",
"    <span class=\"nowrap\">",
"     /k/,",
"    </span>",
"    <span class=\"nowrap\">",
"     /a/,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     /t/.",
"    </span>",
"    As phonemic awareness is gained, the child understands that the letters in written words represent phonemes that create recognizable words when strung together. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Normal reading development'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    This awareness that words, both spoken and written, can be divided into sound segments is difficult for many children to master [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/18\">",
"     18",
"    </a>",
"    ]. Difficulty with phonemic awareness in prereaders is a strong predictor of future reading problems [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/54-57\">",
"     54-57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The phonologic deficit in reading disability is independent of nonphonologic abilities [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/24\">",
"     24",
"    </a>",
"    ]. Higher-order cognitive and linguistic functions involved in comprehension (eg, general intelligence, reasoning, vocabulary, syntax) are not affected. However, the circumscribed phonologic deficit may block access to higher-order processes and the ability to draw meaning from the text. As an example, an individual who knows the definition of the word \"apparition\" will not be able to use that knowledge when presented with the written word unless the word can be decoded and identified [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281043240\">",
"    <span class=\"h2\">",
"     Language impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading comprehension difficulties frequently are rooted in problems understanding spoken language [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/22,58-60\">",
"     22,58-60",
"    </a>",
"    ]. Children who have problems with reading comprehension that cannot be fully explained by difficulties in decoding (ie, dyslexia) often have a history of specific language impairment, low vocabulary,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    poor grammatical skills [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/27,61\">",
"     27,61",
"    </a>",
"    ]. Extracting meaning from written words requires the same skills required to understand spoken language&mdash;vocabulary, knowledge of grammatical structure, and the ability to make inference. Reading comprehension deficits are an increasingly important cause of reading problems in older children as reading materials grow more complex as they proceed through school [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281043258\">",
"    <span class=\"h2\">",
"     Executive function deficits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Executive function refers to higher-order and goal-oriented skills such as memory, capacity for inference, planning, and automatic self-monitoring. Deficits in executive functions are associated with difficulties in reading comprehension even when other known variables are controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Executive function skills become more important as the length and complexity of the text increases. Whether deficits in executive function contribute to problems with phonological",
"    <span class=\"nowrap\">",
"     awareness/word",
"    </span>",
"    identification is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading disability tends to cluster in families with genetic factors accounting for most of the variability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,36,37\">",
"     4,36,37",
"    </a>",
"    ]. Reading disability occurs with 70 to 80 percent concordance in monozygotic twins; the concordance in dizygotic twins is 40 to 50 percent, which is similar to that in non-twin siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,9,63-66\">",
"     4,9,63-66",
"    </a>",
"    ]. The risk of reading disability is 40 to 60 percent among children of affected parents; conversely, 25 to 60 percent of parents of a child with reading disability also meet criteria for reading disability (though they may never have been formally diagnosed) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,9,67,68\">",
"     4,9,67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The genetic contribution to reading disorders almost certainly involves multiple genes that interact with various host and environmental factors to determine the extent of reading disability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Several genes on multiple chromosomes (1, 2, 3, 6, 12, 15, and 18) have been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/45,47,48,71-74\">",
"     45,47,48,71-74",
"    </a>",
"    ]. Evidence is particularly strong for two genes located on chromosome 6p22 (",
"    <em>",
"     DCDC2",
"    </em>",
"    and",
"    <em>",
"     KIAA0310",
"    </em>",
"    ), which are thought to interfere with neuronal migration [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4\">",
"     4",
"    </a>",
"    ]. This mechanism is consistent with the abnormal neuroanatomy described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Neurobiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging and postmortem studies of individuals with reading disabilities demonstrate structural and functional alterations in the regions of the brain responsible for language [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/12,49-51,75-77\">",
"     12,49-51,75-77",
"    </a>",
"    ]. Activation of these regions during functional brain imaging is associated with response to intervention for reading disability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/4,78,79\">",
"     4,78,79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Important neuropathologic correlates of dyslexia include [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/80-84\">",
"     80-84",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disruption of left hemisphere posterior brain systems (ie, the left occipitotemporal word form area) while performing reading tasks.",
"     </li>",
"     <li>",
"      Symmetry or reversal of the normal asymmetry of the planum temporale (which contains portions of the auditory cortex).",
"     </li>",
"     <li>",
"      Increased volume of the posterior language area, and involvement of the inferior frontal gyrus (by microdysgenesis, glial scarring, or both).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Vision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reading disability is not a problem with vision. Children with reading disability do not see letters or words backwards; they have difficulty connecting the letters to sounds [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/24\">",
"     24",
"    </a>",
"    ]. Nonetheless, eye problems that might interfere with learning (eg, refractive error, strabismus) should be identified as early as possible [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/85-87\">",
"     85-87",
"    </a>",
"    ]. Those that are correctable should be managed by an ophthalmologist [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &ldquo;Irlen syndrome&rdquo; is a proposed perceptual disorder that causes distortions when viewing text and contributes to reading difficulty. It is treated with colored lenses (Irlen lenses) or plastic overlays (Irlen overlays). Both the disorder and the intervention are controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6409/abstract/88\">",
"     88",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17592?source=see_link&amp;anchor=H17#H17\">",
"     \"Interventions for children with reading difficulty\", section on 'Unproven therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following resources may provide additional information for parents and clinicians:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      \"Overcoming Dyslexia\" by Sally Shaywitz, MD (2003)",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.ldonline.org/\">",
"       Learning Disabilities Online",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.nationalreadingpanel.org/\">",
"       National Reading Panel Report",
"      </a>",
"      (2000)",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://interdys.org/\">",
"       International Dyslexia Association",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.schwabfoundation.org/About-CHSF/Publications/Schwab-Learning.aspx\">",
"       Schwab Foundation",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.readingrockets.org/\">",
"       Reading Rockets",
"      </a>",
"      for K-3 students",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://fcsn.org/index.php\">",
"       The Federation for Children with Special Needs",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.rfbd.org/\">",
"       Recording for the Blind and Dyslexic",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://fcrr.org/\">",
"       The Florida Center for Reading Research",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/22/29025?source=see_link\">",
"       \"Patient information: Dyslexia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The skills needed for normal reading encompass five domains: phonemic awareness, phonics, sight word acquisition, vocabulary, and comprehension. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Normal reading development'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reading disability (also called dyslexia) is an unexpected difficulty in learning how to read despite adequate intelligence, instruction, and motivation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Reading disability'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Dyslexia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for reading disability include a family history of language, speech, or reading difficulties",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a personal history of speech and language impairment in the preschool years. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reading disability is a heritable disorder with a neurobiologic basis. The mechanisms through which genetic and neuroanatomic factors affect phonologic processing are not entirely clear. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Etiology and pathogenesis of reading disability'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major problem in children with reading disability is a deficit in phonologic processing (the ability to break down spoken and written words into units of sound). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Phonologic deficit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Another common problem is a deficit in reading comprehension (the ability to derive meaning from written text). (See",
"      <a class=\"local\" href=\"#H281043240\">",
"       'Language impairment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H281043258\">",
"       'Executive function deficits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reading disability is not a problem with vision. Children with reading disability do not see letters or words backwards. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Vision'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/1\">",
"      Murnane RJ. Improving the education of children living in poverty. Future Child 2007; 17:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/2\">",
"      Trzesniewski KH, Moffitt TE, Caspi A, et al. Revisiting the association between reading achievement and antisocial behavior: new evidence of an environmental explanation from a twin study. Child Dev 2006; 77:72.",
"     </a>",
"    </li>",
"    <li>",
"     National Center on Secondary Education and Transition. Dropout and Graduation Frequently Asked Questions www.ncset.org/topics/dropout/faqs.asp?topic=36 (Accessed on October 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/4\">",
"      Shaywitz SE, Gruen JR, Shaywitz BA. Management of dyslexia, its rationale, and underlying neurobiology. Pediatr Clin North Am 2007; 54:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/5\">",
"      Grizzle KL. Developmental dyslexia. Pediatr Clin North Am 2007; 54:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/6\">",
"      Alexander AW, Slinger-Constant AM. Current status of treatments for dyslexia: critical review. J Child Neurol 2004; 19:744.",
"     </a>",
"    </li>",
"    <li>",
"     National Reading Panel, National Institute of Child Health and Human Development, National Institutes of Health. Teaching children to read. Reports of the subgroups. file://www.nichd.nih.gov/health/topics/national_reading_panel.cfm (Accessed on October 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/8\">",
"      Schatschneider C, Torgesen JK. Using our current understanding of dyslexia to support early identification and intervention. J Child Neurol 2004; 19:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/9\">",
"      Vellutino FR, Fletcher JM, Snowling MJ, Scanlon DM. Specific reading disability (dyslexia): what have we learned in the past four decades? J Child Psychol Psychiatry 2004; 45:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/10\">",
"      Sesma HW, Mahone EM, Levine T, et al. The contribution of executive skills to reading comprehension. Child Neuropsychol 2009; 15:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/11\">",
"      Cutting LE, Materek A, Cole CA, et al. Effects of fluency, oral language, and executive function on reading comprehension performance. Ann Dyslexia 2009; 59:34.",
"     </a>",
"    </li>",
"    <li>",
"     Fletcher JM, Lyon GR, Fuchs LS, Barnes MA. Learning Disabilities, The Guilford Press, New York 2007.",
"    </li>",
"    <li>",
"     American Psychiatric Association. DSM-V Development. Available at: www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=84 (Accessed on November 07, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/14\">",
"      Catts HW, Hogan TP, Fey ME. Subgrouping poor readers on the basis of individual differences in reading-related abilities. J Learn Disabil 2003; 36:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/15\">",
"      Harlaar N, Cutting L, Deater-Deckard K, et al. Predicting individual differences in reading comprehension: a twin study. Ann Dyslexia 2010; 60:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/16\">",
"      Lyon GR. Learning disabilities. Future Child 1996; 6:54.",
"     </a>",
"    </li>",
"    <li>",
"     Reading disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR&reg;), American Psychiatric Association, Washington, DC 2000. p.429.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/18\">",
"      Francis DJ, Shaywitz SE, Stuebing KK, et al. Developmental lag versus deficit models of reading disability: A longitudinal, individual growth curves analysis. J Educ Psychol 1996; 88:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/19\">",
"      Shaywitz SE, Escobar MD, Shaywitz BA, et al. Evidence that dyslexia may represent the lower tail of a normal distribution of reading ability. N Engl J Med 1992; 326:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/20\">",
"      Shapiro BK, Palmer FB, Antell SE, et al. Detection of young children in need of reading help. Evaluation of specific reading disability formulas. Clin Pediatr (Phila) 1990; 29:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/21\">",
"      Vellutino FR, Scanlon DM, Lyon GR. Differentiating between difficult-to-remediate and readily remediated poor readers: more evidence against the IQ-achievement discrepancy definition of reading disability. J Learn Disabil 2000; 33:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/22\">",
"      Snowling M, Bishop DV, Stothard SE. Is preschool language impairment a risk factor for dyslexia in adolescence? J Child Psychol Psychiatry 2000; 41:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/23\">",
"      Stage SA, Abbott RD, Jenkins JR, Berninger VW. Predicting response to early reading intervention from verbal IQ, reading-related language abilities, attention ratings, and verbal IQ-word reading discrepancy: failure to validate discrepancy method. J Learn Disabil 2003; 36:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/24\">",
"      Shaywitz SE, Shaywitz BA. Dyslexia (specific reading disability). Pediatr Rev 2003; 24:147.",
"     </a>",
"    </li>",
"    <li>",
"     International Dyslexia Association. Definition of dyslexia. interdys.org/FactSheets.htm (Accessed on October 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/26\">",
"      Lyon GR, Shaywitz SE, Shaywitz BA. A definition of dyslexia. Ann Dyslexia 2003; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/27\">",
"      Catts HW, Fey ME, Tomblin JB, Zhang X. A longitudinal investigation of reading outcomes in children with language impairments. J Speech Lang Hear Res 2002; 45:1142.",
"     </a>",
"    </li>",
"    <li>",
"     Lee J, Grigg WS, Donahue PL. The Nation's Report Card: Reading 2007. nces.ed.gov/nationsreportcard/pubs/main2007/2007496.asp#pdflist (Accessed on October 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/29\">",
"      Lerner JW. Educational interventions in learning disabilities. J Am Acad Child Adolesc Psychiatry 1989; 28:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/30\">",
"      D&eacute;monet JF, Taylor MJ, Chaix Y. Developmental dyslexia. Lancet 2004; 363:1451.",
"     </a>",
"    </li>",
"    <li>",
"     Interagency Committee on Learning Disabilities. Learning disabilities: a report to the U.S. Congress, Government Printing Offices, Washington, DC 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/32\">",
"      Shaywitz SE, Fletcher JM, Shaywitz BA. Issues in the definition and classification of attention deficit disorder. Top Lang Disord 1994; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/33\">",
"      Flynn JM, Rahbar MH. Prevalence of reading failure in boys compared with girls. Psychol Sch 1994; 31:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/34\">",
"      Wadsworth SJ, DeFries JC, Stevenson J, et al. Gender ratios among reading-disabled children and their siblings as a function of parental impairment. J Child Psychol Psychiatry 1992; 33:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/35\">",
"      Shaywitz SE, Shaywitz BA, Fletcher JM, Escobar MD. Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA 1990; 264:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/36\">",
"      Snowling MJ, Muter V, Carroll J. Children at family risk of dyslexia: a follow-up in early adolescence. J Child Psychol Psychiatry 2007; 48:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/37\">",
"      Pennington BF, Lefly DL. Early reading development in children at family risk for dyslexia. Child Dev 2001; 72:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/38\">",
"      Torppa M, Eklund K, van Bergen E, Lyytinen H. Parental literacy predicts children's literacy: a longitudinal family-risk study. Dyslexia 2011; 17:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/39\">",
"      Bishop DV, Adams C. A prospective study of the relationship between specific language impairment, phonological disorders and reading retardation. J Child Psychol Psychiatry 1990; 31:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/40\">",
"      Rescorla L. Language and reading outcomes to age 9 in late-talking toddlers. J Speech Lang Hear Res 2002; 45:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/41\">",
"      Litt J, Taylor HG, Klein N, Hack M. Learning disabilities in children with very low birthweight: prevalence, neuropsychological correlates, and educational interventions. J Learn Disabil 2005; 38:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/42\">",
"      Stanovich KE, Siegel LS. Phenotypic performance profile of children with reading disabilities: a regression-based test of the phonological-core variable-difference model. J Educ Psych 1994; 86:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/43\">",
"      Vellutino FR, Scanlon DM, Spearing D. Semantic and phonological coding in poor and normal readers. J Exp Child Psychol 1995; 59:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/44\">",
"      Pennington BF. Genetics of learning disabilities. J Child Neurol 1995; 10 Suppl 1:S69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/45\">",
"      Fisher SE, Francks C, Marlow AJ, et al. Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat Genet 2002; 30:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/46\">",
"      Habib M. The neurological basis of developmental dyslexia: an overview and working hypothesis. Brain 2000; 123 Pt 12:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/47\">",
"      Grigorenko EL, Wood FB, Meyer MS, et al. Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15. Am J Hum Genet 1997; 60:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/48\">",
"      Morris DW, Robinson L, Turic D, et al. Family-based association mapping provides evidence for a gene for reading disability on chromosome 15q. Hum Mol Genet 2000; 9:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/49\">",
"      Temple E, Deutsch GK, Poldrack RA, et al. Neural deficits in children with dyslexia ameliorated by behavioral remediation: evidence from functional MRI. Proc Natl Acad Sci U S A 2003; 100:2860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/50\">",
"      Temple E, Poldrack RA, Protopapas A, et al. Disruption of the neural response to rapid acoustic stimuli in dyslexia: evidence from functional MRI. Proc Natl Acad Sci U S A 2000; 97:13907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/51\">",
"      Shaywitz SE, Shaywitz BA, Pugh KR, et al. Functional disruption in the organization of the brain for reading in dyslexia. Proc Natl Acad Sci U S A 1998; 95:2636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/52\">",
"      Shaywitz SE. Dyslexia. N Engl J Med 1998; 338:307.",
"     </a>",
"    </li>",
"    <li>",
"     Center for the Improvement of Early Reading. Put Reading First: The Research Building Blocks for Teaching Children to Read, 3rd ed, 2006. file://lincs.ed.gov/publications/pdf/PRFbooklet.pdf (Accessed on October 16, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/54\">",
"      Scanlon DM, Vellutino FR. Prerequisite skills, early instruction, and success in first-grade reading: Selected results from a longitudinal study. Ment Retard Dev Disabil Res Rev 1996; 2:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/55\">",
"      Bradley L, Bryant PE. Categorizing sounds and learning to read - a causal connection. Nature 1983; 301:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/56\">",
"      Stanovich KE, Cunningham AE, Cramer BB. Assessing phonological awareness in kindergarten children: issues of task comparability. J Exp Child Psychol 1984; 38:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/57\">",
"      Torgesen JK, Wagner RK, Rashotte CA. Longitudinal studies of phonological processing and reading. J Learn Disabil 1994; 27:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/58\">",
"      Catts HW, Adlof SM, Ellis Weismer S. Language deficits in poor comprehenders: a case for the simple view of reading. J Speech Lang Hear Res 2006; 49:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/59\">",
"      Kelso K, Fletcher J, Lee P. Reading comprehension in children with specific language impairment: an examination of two subgroups. Int J Lang Commun Disord 2007; 42:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/60\">",
"      Wise JC, Sevcik RA, Morris RD, et al. The relationship among receptive and expressive vocabulary, listening comprehension, pre-reading skills, word identification skills, and reading comprehension by children with reading disabilities. J Speech Lang Hear Res 2007; 50:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/61\">",
"      Nation K, Clarke P, Marshall CM, Durand M. Hidden language impairments in children: parallels between poor reading comprehension and specific language impairment? J Speech Lang Hear Res 2004; 47:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/62\">",
"      Goldman SR. Adolescent literacy: learning and understanding content. Future Child 2012; 22:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/63\">",
"      Hensler BS, Schatschneider C, Taylor J, Wagner RK. Behavioral genetic approach to the study of dyslexia. J Dev Behav Pediatr 2010; 31:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/64\">",
"      Harlaar N, Spinath FM, Dale PS, Plomin R. Genetic influences on early word recognition abilities and disabilities: a study of 7-year-old twins. J Child Psychol Psychiatry 2005; 46:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/65\">",
"      Hawke JL, Wadsworth SJ, DeFries JC. Genetic influences on reading difficulties in boys and girls: the Colorado twin study. Dyslexia 2006; 12:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/66\">",
"      Astrom RL, Wadsworth SJ, DeFries JC. Etiology of the stability of reading difficulties: the longitudinal twin study of reading disabilities. Twin Res Hum Genet 2007; 10:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/67\">",
"      Francks C, MacPhie IL, Monaco AP. The genetic basis of dyslexia. Lancet Neurol 2002; 1:483.",
"     </a>",
"    </li>",
"    <li>",
"     Pennington BF, Gilger JW. How is dyslexia transmitted?. In: Developmental dyslexia: neural, cognitive, and genetic mechanisms, Chase CH, Rosen GD, Sherman GF (Eds), York Press, Baltimore 1996 1996. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/69\">",
"      Olson RK. Dyslexia: nature and nurture. Dyslexia 2002; 8:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/70\">",
"      Schumacher J, Hoffmann P, Schm&auml;l C, et al. Genetics of dyslexia: the evolving landscape. J Med Genet 2007; 44:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/71\">",
"      Smith SD, Pennington BF, Kimberling WJ, Ing PS. Familial dyslexia: use of genetic linkage data to define subtypes. J Am Acad Child Adolesc Psychiatry 1990; 29:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/72\">",
"      Fagerheim T, Raeymaekers P, T&oslash;nnessen FE, et al. A new gene (DYX3) for dyslexia is located on chromosome 2. J Med Genet 1999; 36:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/73\">",
"      Petryshen TL, Kaplan BJ, Hughes ML, et al. Supportive evidence for the DYX3 dyslexia susceptibility gene in Canadian families. J Med Genet 2002; 39:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/74\">",
"      Roeske D, Ludwig KU, Neuhoff N, et al. First genome-wide association scan on neurophysiological endophenotypes points to trans-regulation effects on SLC2A3 in dyslexic children. Mol Psychiatry 2011; 16:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/75\">",
"      Shaywitz BA, Shaywitz SE, Pugh KR, et al. Disruption of posterior brain systems for reading in children with developmental dyslexia. Biol Psychiatry 2002; 52:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/76\">",
"      Frank Y, Pavlakis SG. Brain imaging in neurobehavioral disorders. Pediatr Neurol 2001; 25:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/77\">",
"      Eckert MA, Leonard CM, Richards TL, et al. Anatomical correlates of dyslexia: frontal and cerebellar findings. Brain 2003; 126:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/78\">",
"      Aylward EH, Richards TL, Berninger VW, et al. Instructional treatment associated with changes in brain activation in children with dyslexia. Neurology 2003; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/79\">",
"      Gaab N, Gabrieli JD, Deutsch GK, et al. Neural correlates of rapid auditory processing are disrupted in children with developmental dyslexia and ameliorated with training: an fMRI study. Restor Neurol Neurosci 2007; 25:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/80\">",
"      Shaywitz SE, Shaywitz BA. Dyslexia (specific reading disability). Biol Psychiatry 2005; 57:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/81\">",
"      Galaburda AM. Neuropathologic correlates of learning disabilities. Semin Neurol 1991; 11:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/82\">",
"      Hier DB, LeMay M, Rosenberger PB, Perlo VP. Developmental dyslexia. Evidence for a subgroup with a reversal of cerebral asymmetry. Arch Neurol 1978; 35:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/83\">",
"      Haslam RH, Dalby JT, Johns RD, Rademaker AW. Cerebral asymmetry in developmental dyslexia. Arch Neurol 1981; 38:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/84\">",
"      Larsen JP, H&oslash;ien T, Lundberg I, Odegaard H. MRI evaluation of the size and symmetry of the planum temporale in adolescents with developmental dyslexia. Brain Lang 1990; 39:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/85\">",
"      American Academy of Pediatrics, Section on Ophthalmology, Council on Children with Disabilities, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Joint statement--Learning disabilities, dyslexia, and vision. Pediatrics 2009; 124:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/86\">",
"      Keys MP. The pediatrician's role in reading disorders. Pediatr Clin North Am 1993; 40:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/87\">",
"      Olitsky SE, Nelson LB. Reading disorders in children. Pediatr Clin North Am 2003; 50:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6409/abstract/88\">",
"      Ritchie SJ, Della Sala S, McIntosh RD. Irlen colored overlays do not alleviate reading difficulties. Pediatrics 2011; 128:e932.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 598 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-A58E39C754-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6409=[""].join("\n");
var outline_f6_16_6409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL READING DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TERMINOLOGY AND CONCEPTUAL FRAMEWORK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reading difficulty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Reading disability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Dimensional model",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Discrepancy model",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Dyslexia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H539446524\">",
"      Reading comprehension deficit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Reading difficulties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Reading disabilities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Environmental risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ETIOLOGY AND PATHOGENESIS OF READING DISABILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Phonologic deficit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281043240\">",
"      Language impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281043258\">",
"      Executive function deficits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Neurobiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Vision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/598\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/598|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/25/36253\" title=\"table 1\">",
"      Language literacy milestones",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/21/1370?source=related_link\">",
"      Clinical features and evaluation of reading difficulty in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/22/10599?source=related_link\">",
"      Emergent literacy including language development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17592?source=related_link\">",
"      Interventions for children with reading difficulty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/22/29025?source=related_link\">",
"      Patient information: Dyslexia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=related_link\">",
"      Specific learning disabilities in children: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37306?source=related_link\">",
"      Specific learning disabilities in children: Educational management",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_16_6410="Clinical features and diagnosis of sepsis in term and late preterm infants";
var content_f6_16_6410=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of sepsis in term and late preterm infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/16/6410/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/16/6410/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis is an important cause of morbidity and mortality among newborn infants. Although the incidence of sepsis in term and late preterm infants is low, the potential for serious adverse outcomes, including death, is of such great consequence that caregivers should have a low threshold for evaluation and treatment for possible sepsis in any infant regardless of the birth weight or gestational age.",
"   </p>",
"   <p>",
"    The epidemiology, clinical features, diagnosis, and evaluation of sepsis in term and late preterm infants will be reviewed here. The management and outcome of sepsis in term and late preterm infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=see_link\">",
"     \"Treatment and outcome of sepsis in term and late preterm infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following terms will be used throughout this discussion on neonatal sepsis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonatal sepsis is a clinical syndrome in an infant 28 days of life or younger, manifested by systemic signs of infection",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      isolation of a bacterial pathogen from the blood stream [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Term infants are those born at a gestational age of 37 weeks or greater.",
"     </li>",
"     <li>",
"      Late preterm",
"      <strong>",
"       infants",
"      </strong>",
"      (also called",
"      <strong>",
"       near-term",
"      </strong>",
"      <strong>",
"       infants",
"      </strong>",
"      ) are those born between 34 and 36 completed weeks of gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22713?source=see_link\">",
"       \"Late preterm infants\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Preterm infants are those born at less than 34 weeks of gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sepsis is classified according to the infant's age at the onset of symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early-onset sepsis is defined as the onset of symptoms within the first days of life. There is variability of the age at onset, with some experts defining early-onset sepsis as bloodstream infection at &le;72 hours of age [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/3\">",
"       3",
"      </a>",
"      ], and others defining early-onset group B streptococcal (GBS) disease as infection with the onset of symptoms through day six of life [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Late-onset sepsis is defined as the onset of symptoms after the first days of life. Similar to early-onset sepsis, there is variability in its definition ranging from an onset at &gt;72 hours or &ge;7 days of age [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H2#H2\">",
"       \"Group B streptococcal infection in neonates and young infants\", section on 'Terminology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Early-onset sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early-onset infection is usually due to vertical transmission by ascending contaminated amniotic fluid or during vaginal delivery from bacteria colonizing or infecting the mother's lower genital tract [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ]. As a result, the risk for sepsis increases from 1 to 4 percent in neonates born to mothers with chorioamnionitis.",
"   </p>",
"   <p>",
"    Maternal group B streptococcal (GBS) bacteriuria during the current pregnancy, prior delivery of an infant with GBS disease, and maternal colonization are risk factors for early-onset GBS sepsis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H9#H9\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Late-onset sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late-onset infections can be acquired by the two following mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal vertical transmission, resulting in initial neonatal colonization that evolves into later infection.",
"     </li>",
"     <li>",
"      Horizontal transmission from direct contact with care providers or environmental sources. Disruption of the intact skin or mucosa, which can be due to invasive procedures (eg, intravascular catheter), increases the risk of late-onset infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Late-onset sepsis is uncommonly associated with maternal obstetrical complications. Risk factors can include use of forceps during delivery or electrodes placed for intrauterine monitoring, which penetrate the neonatal defensive epithelial barriers of the skin and mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Metabolic factors, including hypoxia, acidosis, hypothermia, and inherited metabolic disorders (eg, galactosemia), are likely to contribute to risk for and severity of neonatal sepsis. These factors are thought to disrupt the neonate's host defenses (ie, immunologic response) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall incidence of neonatal sepsis ranges from one to five cases per 1000 live births. The estimated incidence is lower in term infants, with a reported rate of one to two cases per 1000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increased risk of sepsis in preterm infants was illustrated in a population-based cohort study of neonatal group B streptococcal (GBS) disease with reported attack rates that were sevenfold higher for infants with a birth weight &lt;1500 g compared with infants with a birth weight &ge;2500 g [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/8\">",
"     8",
"    </a>",
"    ]. In late preterm infants, the reported incidences of early- and late-onset sepsis were four and six per 1000 admissions to neonatal intensive care units (NICU), respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/9\">",
"     9",
"    </a>",
"    ]. Black race has been identified as an independent risk factor for early- and late-onset GBS sepsis. Reasons for the disproportionately high disease burden among black populations cannot be fully explained by prematurity, adequacy of prenatal care, or socioeconomic status [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=see_link&amp;anchor=H7#H7\">",
"     \"Group B streptococcal infection in neonates and young infants\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of early-onset sepsis has decreased primarily as a reduction of GBS infections due to the use of intrapartum antibiotic prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. This was illustrated by a retrospective review of data (blood, urine, and cerebrospinal fluid cultures) from 322 neonatal units managed by Pediatrix Medical group from two time periods before (1997 to 2001) and after (2002 to 2010) the initiation of universal intrapartum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/14\">",
"     14",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of early-onset serious bacterial infections (SBIs) due to GBS decreased from 3.5 to 2.6 per 1000 admissions between the two time periods. In this cohort, early-onset GBS disease was mainly observed in term infants (74 percent) and late preterm infants (10 percent).",
"     </li>",
"     <li>",
"      In contrast, the incidence of late-onset GBS disease increased from 0.8 to 1.1 per 1000 admissions. Late-onset GBS disease was primarily seen in preterm infants with a gestational age below 34 weeks (83 percent).",
"     </li>",
"     <li>",
"      The incidence for early-onset SBIs due to Escherichia coli (E. coli) remained stable (1.4 per 1000 admissions), whereas the incidence of late-onset E. coli SBIs increased from 2.2 to 2.5 per 1000 admissions between the two time periods. SBIs due to E. coli were observed primarily in preterm infants for both early-onset (90 percent of cases) and late-onset disease (88 percent).",
"     </li>",
"     <li>",
"      The overall incidence in the United States of early-onset GBS invasive infection reported through the Centers for Disease Control and Prevention Active Bacterial Cole Surveillance network has declined from 0.6 per 1000 live births in 2000 to 0.25 per 1000 live births in 2011 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. The incidence of late-onset GBS invasive infection has remained stable in the same interval (0.4 per 1000 live births in 2000 and 0.29 per 1000 live births in 2011).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study using prospective data from the National Institute of Child Health and Human Development (NICHHD) Neonatal Network of infants born between 2006 and 2009, the overall rate of early-onset sepsis (defined as positive blood or cerebrospinal fluid cultures) was 0.98 cases per 1000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/17\">",
"     17",
"    </a>",
"    ]. Infection rate increased with decreasing gestational age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bacteria that commonly cause neonatal sepsis and their relative frequency in early- and late-onset sepsis are shown in the linked table (",
"    <a class=\"graphic graphic_table graphicRef61061 \" href=\"UTD.htm?39/3/39996\">",
"     table 1",
"    </a>",
"    ). The patterns of pathogens associated with neonatal sepsis have changed over time as reflected by longitudinal databases from single tertiary centers [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Currently, Group B streptococcus (GBS) and Escherichia coli (E. coli) are the most common causes of both early- and late-onset sepsis. The incidence of early-onset GBS has declined by 80 percent with the use of intrapartum antibiotic prophylaxis (IAP); however, GBS and E. coli continue to account for approximately two-thirds of early-onset infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/11,18,19\">",
"     11,18,19",
"    </a>",
"    ]. The use of IAP to prevent early-onset GBS infection appears to also reduce the risk of early-onset E. coli infection in term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/20\">",
"     20",
"    </a>",
"    ]. In the previously mentioned report from the National Institute of Child Health and Human Development (NICHHD) Neonatal Network, most of the infants with GBS sepsis were term infants (73 percent), whereas the majority of infants with E coli infections were preterm (81 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/17\">",
"     17",
"    </a>",
"    ]. In this cohort of almost 400,000 infants, GBS screening was performed in 67 percent of mothers with infected term infants and in 58 percent of infected preterm infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other bacterial agents associated with neonatal sepsis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Listeria monocytogenes, although a well-recognized cause of early-onset sepsis, only accounts for rare sporadic cases of neonatal sepsis, and is more commonly seen during an outbreak of listeriosis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/21,22\">",
"       21,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Staphylococcus aureus (S. aureus), including community-acquired methicillin-resistant S. aureus, is an emerging pathogen in neonatal sepsis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/23\">",
"       23",
"      </a>",
"      ]. Bacteremic staphylococcal infections in term infants usually occur in association with skin, bone, or joint sites of involvement.",
"     </li>",
"     <li>",
"      Enterococcus, a commonly encountered pathogen among preterm infants, is a rare cause of sepsis in otherwise healthy term newborn infants.",
"     </li>",
"     <li>",
"      Other gram-negative bacteria (including Klebsiella, Enterobacter, and Citrobacter spp.) and Pseudomonas aeruginosa are associated with late-onset infection, especially in infants admitted to the neonatal intensive care units (NICU) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Coagulase negative staphylococcus often is a cause of nosocomial infection in ill infants (especially premature infants",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infants who have indwelling intravascular catheters). It may be considered a contaminant in otherwise healthy term infants who have not undergone invasive procedures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the signs and symptoms of sepsis are subtle and nonspecific, identification of risk factors and any deviation from an infant's usual pattern of activity or feeding should be regarded as a possible indication of systemic bacterial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common clinical signs include temperature instability (primarily fever), as well as respiratory, gastrointestinal, and neurologic abnormalities (",
"    <a class=\"graphic graphic_table graphicRef72985 \" href=\"UTD.htm?37/52/38731\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, fetal and neonatal distress during labor and delivery are associated with neonatal sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Fetal and delivery room distress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal and neonatal distress during labor and delivery can be the earliest sign of neonatal sepsis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrapartum fetal tachycardia can be due to fetal stress, which can be caused by intraamniotic infection that presents as early-onset neonatal sepsis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/40/24202?source=see_link&amp;anchor=H12#H12\">",
"       \"Overview of the general approach to diagnosis and treatment of fetal cardiac arrhythmias\", section on 'Tachyarrhythmias'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Meconium-stained amniotic fluid can be another sign of fetal distress. It is associated with a twofold increase for sepsis in infants who did not receive intrapartum antibiotics [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21768?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical features and diagnosis of meconium aspiration syndrome\", section on 'Meconium passage'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low Apgar score, a measure of neonatal distress in the first minutes after delivery, is associated with neonatal sepsis. In a case-control study from the state of Washington, infants with an Apgar score &le;6 at five minutes had a 36-fold higher likelihood of sepsis compared with those with Apgar scores &ge;7 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Temperature instability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The temperature of a septic infant can be elevated, depressed, or normal. Term infants with sepsis are more likely to be febrile than preterm infants, whereas, preterm infants are more likely to be hypothermic [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Temperature elevation without infection in full-term infants is concerning and, if persistent, is indicative of neonatal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. This was illustrated in an observational study of term infants that found 1 percent of all infants cared for in the normal nursery were febrile, defined as a temperature &ge;37.8&ordm;C (100&ordm;F) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/28\">",
"     28",
"    </a>",
"    ]. Of these 100 febrile infants, 10 had culture-proven sepsis (10 percent), and 45 had symptoms compatible with bacterial disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other findings associated with neonatal sepsis and their approximate frequencies are listed below (",
"    <a class=\"graphic graphic_table graphicRef72985 \" href=\"UTD.htm?37/52/38731\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Jaundice: 35 percent",
"     </li>",
"     <li>",
"      Respiratory distress (tachypnea, grunting, flaring of the nasal alae, retractions, and decreased breath sounds): 33 percent",
"     </li>",
"     <li>",
"      Hepatomegaly: 33 percent",
"     </li>",
"     <li>",
"      Anorexia: 28 percent",
"     </li>",
"     <li>",
"      Vomiting: 25 percent",
"     </li>",
"     <li>",
"      Lethargy: 25 percent",
"     </li>",
"     <li>",
"      Cyanosis: 24 percent",
"     </li>",
"     <li>",
"      Apnea: 22 percent",
"     </li>",
"     <li>",
"      Abdominal distension: 17 percent",
"     </li>",
"     <li>",
"      Irritability: 15 percent",
"     </li>",
"     <li>",
"      Diarrhea: 11 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the signs and symptoms of sepsis are subtle and nonspecific, laboratory evaluation is performed in any infant with identifiable risk factors, physical findings consistent with sepsis, or who deviates in any way from the usual pattern of activity or feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. This approach is consistent with that outlined by the 2012 American Academy of Pediatrics (AAP) clinical report for infants with suspected or proven early-onset sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The routine newborn assessment includes a review of the pregnancy, labor, and delivery, including risk factors for sepsis and a comprehensive physical examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24922?source=see_link\">",
"     \"Assessment of the newborn infant\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H8\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Maternal and neonatal risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each neonate should be evaluated for the presence of the following maternal and neonatal factors that are associated with an increased risk of sepsis, particularly Group B streptococcal (GBS) infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5,25\">",
"     5,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intrapartum maternal temperature &ge;38&ordm;C (100.4&ordm;F)",
"     </li>",
"     <li>",
"      Delivery at &lt;37 weeks gestation",
"     </li>",
"     <li>",
"      Chorioamnionitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=see_link&amp;anchor=H7#H7\">",
"       \"Intraamniotic infection (chorioamnionitis)\", section on 'Clinical presentation and diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Five minute Apgar score &le;6 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Evidence of fetal distress",
"     </li>",
"     <li>",
"      Maternal GBS colonization",
"     </li>",
"     <li>",
"      Membrane rupture &ge;18 hours &ndash; The risk of proven sepsis increases 10-fold to 1 percent when membranes are ruptured beyond 18 hours [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use and duration of maternal intrapartum antibiotic prophylaxis (IAP) also should be noted, as IAP reduces the risk of GBS infection. However, in the previously mentioned National Institute of Child Health and Human Development (NICHHD) report, about half of the mothers who delivered infants with early-onset sepsis received intrapartum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/17\">",
"     17",
"    </a>",
"    ], so one cannot exclude the possibility of sepsis on the basis that an infant's mother was administered intrapartum antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=see_link\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a case-control study of infants &gt;34 weeks gestation born between 1993 and 2004, multivariate analysis demonstrated an increasing risk of neonatal sepsis as intrapartum temperature rose above 38.1&ordm;C (100.5&ordm;F), with increasing duration of rupture of membranes, and with both late preterm and postterm delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/30\">",
"     30",
"    </a>",
"    ]. Decreased risk of infection was associated with administration of any form of intrapartum antibiotic given &gt;4 hours before delivery. These factors were used to develop a predictive model for neonatal sepsis, which needs to be validated in future prospective studies.",
"   </p>",
"   <p>",
"    The management of infants whose mother has received IAP for GBS infection is reviewed separately (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2552?source=see_link&amp;anchor=H2901877#H2901877\">",
"     \"Management of the infant whose mother has received group B streptococcal chemoprophylaxis\", section on 'Overview of management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory assessment includes cultures of body fluids that confirm the presence or absence of a bacterial pathogen, and other studies that are used to evaluate the likelihood of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Blood culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definitive diagnosis of neonatal sepsis is established by a positive blood culture. The sensitivity of blood culture to detect neonatal bacteremia is dependent upon the number of cultures obtained and the volume of blood used to inoculate each culture bottle. The blood culture can be obtained by venipuncture or arterial puncture, or by sampling from a newly inserted umbilical artery catheter.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Number of cultures &ndash; The sensitivity of one blood culture to detect neonatal bacteremia is approximately 90 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/6,31\">",
"       6,31",
"      </a>",
"      ]. However, multiple cultures can delay the initiation of therapy, which can increase mortality and morbidity in this highly vulnerable population. As a result, we obtain at least one culture prior to initiating empirical antibiotic therapy in neonates with a high clinical suspicion for sepsis, although other institutions may routinely obtain two blood cultures. The clinical course and other tests can be used to make a clinical diagnosis of sepsis in a small subset of infants with a sterile blood culture(s), who are then treated with a complete course of antibiotic therapy.",
"     </li>",
"     <li>",
"      Volume of blood &ndash; When a single blood culture bottle is used, a minimum blood volume of 1 mL is desirable for optimal detection of bacteremia [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"       5",
"      </a>",
"      ]. Dividing this volume into two aliquots of 0.5 mL to inoculate anaerobic and aerobic culture bottles is likely to decrease the sensitivity, as in vitro data suggest that a 0.5 mL sample would not reliably detect low levels of bacteremia [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/32\">",
"       32",
"      </a>",
"      ]. However, in patients with a high level of bacteremia, smaller volumes usually are adequate for a positive blood culture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Automated systems for continuous monitoring of blood cultures are routinely used in the United States and have shortened the time to identify positive blood cultures. In most cases of neonatal sepsis, a blood culture will become positive within 24 to 36 hours.",
"   </p>",
"   <p>",
"    This was illustrated in a study of 455 positive blood cultures from 222 preterm and term infants evaluated for neonatal sepsis. An automated blood culture system identified 77, 89, and 94 percent of all microorganisms within 24, 36, and 48 hours of incubation in aerobic conditions, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/33\">",
"     33",
"    </a>",
"    ]. When common bacterial pathogens for neonatal sepsis were reviewed, 97 and 99 percent of cultures were positive by 24 and 36 hours. These pathogens included GBS, S. agalactiae, E. coli, L. monocytogenes, S. aureus, Klebsiella pneumoniae, Serratia marcescens, Enterobacter cloacae, Morganella morganii, Pseudomonas aeruginosa, Enterococcus, and Streptococcus pyogenes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H686757573\">",
"    <span class=\"h3\">",
"     Complete blood count",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete blood count (CBC) obtained 6 to 12 hours after delivery may be helpful in the evaluation of early-onset sepsis. Although both the absolute neutrophil and the ratio of immature to total neutrophil counts",
"    <span class=\"nowrap\">",
"     (I/T",
"    </span>",
"    ratio) have been used as markers for neonatal sepsis, they are more useful in identifying neonates who are unlikely to have sepsis than identifying those with sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a multicenter study of 67,623 infants born at &ge;34 weeks gestation, in whom both a blood culture and CBC were performed within the first 24 hours of life, low white blood cell count (WBC)",
"    <span class=\"nowrap\">",
"     (&lt;5000/microL);",
"    </span>",
"    absolute neutropenia (&lt;1000",
"    <span class=\"nowrap\">",
"     neutrophils/microL),",
"    </span>",
"    relative neutropenia (&lt;5000",
"    <span class=\"nowrap\">",
"     neutrophils/microL);",
"    </span>",
"    or an",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio of 0.3 or higher were associated with blood culture-proven, early-onset disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/34\">",
"     34",
"    </a>",
"    ]. However, none of the tests were sufficiently sensitive to reliably predict neonatal sepsis. The authors also found that a CBC was more helpful as a predictor for sepsis if obtained after four hours of age because the WBC and absolute neutrophil count (ANC) normally increase during the first six hours of life.",
"   </p>",
"   <p>",
"    Similar results were seen in another multicenter study of 166,092 neonates with suspected early-onset of sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/35\">",
"     35",
"    </a>",
"    ]. This study included both term and preterm infants, and the mean gestational age of the cohort was 34.6 weeks. The probability of a positive blood culture within the first three days of life increased with a low WBC",
"    <span class=\"nowrap\">",
"     (&lt;5000/microL),",
"    </span>",
"    absolute neutropenia (&lt;1000",
"    <span class=\"nowrap\">",
"     neutrophils/microL),",
"    </span>",
"    and an elevated",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio. However, sensitivities of all indices were poor and insufficient to accurately diagnose neonatal sepsis.",
"   </p>",
"   <p>",
"    In another analysis of the same cohort of patients, late-onset sepsis (defined as a positive culture between day of life 4 and 120) was associated with both low and high WBC (&lt;1000 and",
"    <span class=\"nowrap\">",
"     &gt;50,000/microL),",
"    </span>",
"    high absolute neutrophil count",
"    <span class=\"nowrap\">",
"     (&gt;17,670/microL),",
"    </span>",
"    elevated",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio of 0.2 or higher, and low platelet count",
"    <span class=\"nowrap\">",
"     (&lt;50,000/microL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/36\">",
"     36",
"    </a>",
"    ]. However, sensitivity also was inadequate to reliably make the diagnosis of late-onset sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H686757902\">",
"    <span class=\"h4\">",
"     Total neutrophil count",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although both elevated WBC and low neutrophil counts can be predictive of neonatal sepsis, neutropenia may be a better marker because it has greater specificity, as few conditions other than sepsis and preeclampsia depress the neutrophil count of neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Defining neutropenia in the neonate can be challenging, as neutrophil counts vary with gestational age (neutrophil counts decrease with decreasing gestational age), type of delivery (they are lower in infants born by cesarean delivery), site of sampling (neutrophil counts are lower in arterial than in venous samples), altitude (neutrophil counts are higher at elevated altitudes) and timing after delivery. In a study of 30,254 infants born at 23 to 42 weeks of gestation that used modern cell-count instruments to determine neutrophil counts, the lower limit of a normal neutrophil count for infants &gt;36 weeks of gestation was",
"    <span class=\"nowrap\">",
"     3500/microL",
"    </span>",
"    at birth and",
"    <span class=\"nowrap\">",
"     7500/microL",
"    </span>",
"    six to eight hours after delivery (",
"    <a class=\"graphic graphic_figure graphicRef83661 \" href=\"UTD.htm?25/42/26286\">",
"     figure 1",
"    </a>",
"    ). For infants born at 28 through 36 weeks of gestation, the lower limits of normal for neutrophil counts at birth and at six to eight hours after birth were",
"    <span class=\"nowrap\">",
"     1000/microL",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     1500/microL,",
"    </span>",
"    respectively (",
"    <a class=\"graphic graphic_figure graphicRef83824 \" href=\"UTD.htm?38/42/39586\">",
"     figure 2",
"    </a>",
"    ). These results were similar to those obtained by an earlier study published in 1979, which had defined neutropenia in term infants as below 7800 microL, 12 to 14 hours after delivery (",
"    <a class=\"graphic graphic_figure graphicRef83825 \" href=\"UTD.htm?7/2/7215\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Total neutrophil counts decreased with decreasing gestational age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H686757909\">",
"    <span class=\"h4\">",
"     I/T ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elevated",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio has the best sensitivity of the neutrophil indices for predicting neonatal sepsis. In healthy term infants, the 90",
"    <sup>",
"     th",
"    </sup>",
"    percentile for",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio is 0.27. Exhaustion of the bone marrow reserves will result in low band counts and lead to falsely low ratios.",
"   </p>",
"   <p>",
"    However, this test is limited by the wide range of normal values, which reduces its positive predictive value, especially in asymptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/39\">",
"     39",
"    </a>",
"    ]. The high negative predictive value (96 to 100 percent) of the",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio in combination with other tests or the presence of risk factors may be useful as an initial screen for neonatal sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/25,40,41\">",
"     25,40,41",
"    </a>",
"    ]. This was illustrated in a study of 3154 neonates who had a blood culture drawn at less than 24 hours and two serial WBC measurements with manual differentials [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/42\">",
"     42",
"    </a>",
"    ]. In this cohort, 31 infants had a positive blood culture, of which 23 were considered to have true sepsis (0.73 percent) and eight (0.25 percent) to have contaminants. An abnormal",
"    <span class=\"nowrap\">",
"     I/T",
"    </span>",
"    ratio was observed in all neonates with true sepsis and 119 with presumed sepsis as well as 1473 neonates without infection. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Clinical diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10054?source=see_link&amp;anchor=H16#H16\">",
"     \"Evaluating diagnostic tests\", section on 'How well does the test perform in specific populations?'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of acute phase reactants have been used to identify the septic newborn. Many of these tests are highly sensitive (ie, do not miss cases of sepsis); however, they lack specificity (ie, they do not reliably exclude sepsis when it is not present), resulting in a poor predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Clinical diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Inflammatory mediators'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      C-reactive protein (CRP) &ndash; CRP, an acute phase reactant, increases in inflammatory conditions, including sepsis. A CRP value that is greater than 1.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      is 90 percent sensitive in detecting neonatal sepsis but is nonspecific because of the number of other noninfectious inflammatory conditions including maternal fever, fetal distress, stressful delivery, perinatal asphyxia, meconium aspiration, and intraventricular hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/44\">",
"       44",
"      </a>",
"      ]. In addition, CRP is not a sensitive test at birth because it requires an inflammatory response to increase its level [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"       5",
"      </a>",
"      ]. As a result, a single measurement of CRP soon after birth is not a useful marker in the diagnosis of neonatal sepsis.",
"      <br/>",
"      <br/>",
"      However, sequential assessment of CRP values is useful in supporting a diagnosis of sepsis. If the CRP level remains persistently normal, neonatal bacterial sepsis is unlikely [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"       5",
"      </a>",
"      ]. It also is helpful in guiding the duration of antibiotic therapy in suspected neonatal bacterial infection. Infants with elevated CRP levels that decrease to &lt;1.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      24 to 48 hours after the start of antibiotic therapy typically are uninfected and generally do not require further antibiotic treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/45\">",
"       45",
"      </a>",
"      ]. However, data are insufficient to determine the duration of antibacterial therapy in an infant with an elevated value &ge;1",
"      <span class=\"nowrap\">",
"       mg/dL.",
"      </span>",
"     </li>",
"     <li>",
"      Cytokines &ndash; Both proinflammatory (interleukin-2 [IL-2], IL-6, interferon gamma, and tumor necrosis factor alpha) and anti-inflammatory cytokines (IL-4 and IL-10) are increased in infected infants compared with those without infections [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]. However, these cytokines are not routinely measured because of their high cost of testing and because no single biomarker or panel of tests is sufficiently sensitive to reliably detect neonatal sepsis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Procalcitonin &ndash; Procalcitonin is the peptide precursor of calcitonin. It is released by parenchymal cells in response to bacterial toxins, leading to elevated serum levels in patients with bacterial infections. Several observational studies have suggested that procalcitonin may be a useful marker to detect serious bacterial infections in young febrile infants [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/49\">",
"       49",
"      </a>",
"      ]. Limited data in preterm infants report that elevated procalcitonin (greater than 0.5",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      is equivalent or better than CRP in detecting bacterial infection [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/46\">",
"       46",
"      </a>",
"      ]. Although procalcitonin is a promising marker, it appears not to be sufficiently reliable as the sole or main diagnostic indicator for neonatal sepsis, and, at this time, it is not routinely available in hospital laboratories.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further research, which better understands the neonatal inflammatory response to sepsis, may result in the identification of sensitive and specific markers of inflammation or the development of pathogen-specific rapid diagnostic tests for early detection of neonatal sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/46\">",
"     46",
"    </a>",
"    ]. With a sensitive and specific marker for systemic bacterial infection, the management of neonatal sepsis would be significantly altered so that antimicrobial therapy could be safely withheld in infants for whom sepsis is unlikely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lumbar puncture (LP) should be considered in all neonates for whom blood culture evaluation for sepsis is performed, because clinical signs suggesting meningitis can be lacking in young infants.",
"   </p>",
"   <p>",
"    In a retrospective study of all neonates born in United States army hospitals from 1988 to 1992, 8 of the 36 term infants with meningitis had no symptoms referable to the central nervous system, and had sterile blood cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/50\">",
"     50",
"    </a>",
"    ]. In addition, three infants with both positive cerebrospinal fluid (CSF) and blood cultures were asymptomatic.",
"   </p>",
"   <p>",
"    In our practice, we always perform a LP for symptomatic term infants. For asymptomatic term infants, meningeal doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    in combination are initiated after evaluation that includes a blood culture. The CSF should be sent for culture, Gram stain, cell count, and protein and glucose concentration to determine whether the infant has meningitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H20\">",
"     'Clinical diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The decision of whether or when to perform a LP (for CSF analysis and culture) remains controversial. The approach outlined by the 2012 AAP clinical report recommends that LP be performed for an infant with any of the following clinical conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A positive blood culture",
"     </li>",
"     <li>",
"      Clinical findings that are highly suggestive of sepsis (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Laboratory data strongly suggestive of sepsis",
"     </li>",
"     <li>",
"      Worsening clinical status while on antibiotic therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When an infant is critically ill or likely to have cardiovascular or pulmonary compromise from the procedure, the LP can be deferred until the patient&rsquo;s status has stabilized.",
"   </p>",
"   <p>",
"    It is our practice to provide meningeal doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    after a sepsis evaluation that does not include an initial LP. Blood culture can be negative in as many as 38 percent of infants with meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5,51,52\">",
"     5,51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When CSF is obtained, it should be sent for Gram stain, routine culture, cell count with differential and protein and glucose concentrations.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of neonatal bacterial meningitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Urine culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urine culture obtained by catheter or bladder tap should be included in the sepsis evaluation for infants &gt;6 days of age. A urine culture need not be routinely performed in the evaluation of an infant &le;6 days of age because a positive urine culture in this setting is a reflection of high-grade bacteremia rather than an isolated urinary tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5,53\">",
"     5,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/59/14264?source=see_link\">",
"     \"Urinary tract infections in newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H686757402\">",
"    <span class=\"h3\">",
"     Other sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with late-onset infection, cultures should be obtained from any other potential foci of infection (eg, purulent eye drainage or pustules).",
"   </p>",
"   <p>",
"    In infants with early-onset infection, Gram stains of gastric aspirates are of limited values as are bacterial cultures of body surface areas (eg, axilla, groin, and external ear canal) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tracheal aspirate specimens can be of value if obtained immediately after intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"     5",
"    </a>",
"    ]. However, they may reflect lower respiratory tract colonization rather than indicating a causative pathogen in an infant who has been intubated for several days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H686757410\">",
"    <span class=\"h3\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiography should be obtained in an infant with respiratory distress. Localized infiltrates may be due to pneumonia. Cultures should also be obtained from any other potential foci of infection (eg, purulent eye drainage or pustules).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The isolation of a pathogenic bacterium from a blood culture is the only method to truly confirm the diagnosis of neonatal sepsis. However, there is a significant time lag before blood culture results are available, and blood cultures may lead to false negative results in about 10 percent of septic cases. As a result, clinical assessment and laboratory tests are used to identify neonates at significant risk for sepsis so that empiric antibiotic treatment may be initiated while awaiting blood culture results. In addition, clinical assessment, subsequent laboratory tests, and the clinical course are used to make a clinical diagnosis of sepsis in the small subset of infants with probable sepsis but with a sterile blood culture, who would than receive a complete course of antibiotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of clinical diagnosis are to identify and treat all infants with bacterial sepsis, and minimize the testing and treatment of patients who are not infected. Making a clinical diagnosis is challenging, as there is no specific finding or test that reliably identifies septic asymptomatic infants from uninfected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/54\">",
"     54",
"    </a>",
"    ]. Screening protocols used to identify serious bacterial infections (SBI) in febrile infants two to three months of age are inadequate in neonates, as they have an unacceptable rate of failing to identify neonates with SBI [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40550?source=see_link&amp;anchor=H6#H6\">",
"     \"Strategies for the evaluation of fever in neonates and infants (less than three months of age)\", section on 'Limitations in neonates'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H12\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Despite these difficulties, a composite of observational assessment and laboratory testing is typically used to make the clinical diagnosis of neonatal sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/40\">",
"     40",
"    </a>",
"    ]. The criteria used are usually broad, thereby ensuring that all infected infants are identified and treated, but at the cost of testing and treating a significant number of uninfected infants.",
"   </p>",
"   <p>",
"    These points were illustrated in a study conducted during the birth hospitalization of infants born with a birth weight of at least 2000 g without a major congenital anomaly at six Kaiser Permanente hospitals between 1995 and 1996 as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation with a complete blood count",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      blood culture for sepsis was performed in 15 percent of the entire cohort of 18,299 infants. Laboratory testing was performed by 12 hours of age for 90 percent of the patients.",
"     </li>",
"     <li>",
"      Of the 2785 infants evaluated for sepsis, about half had clinical signs consistent with infection.",
"     </li>",
"     <li>",
"      Among the 1275 assessed infants who were asymptomatic, evaluation for sepsis was performed because of identified risk factors, including rupture of membranes for longer than 18 hours (34 percent), maternal chorioamnionitis (33 percent), maternal fever &gt;100.4&ordm;F (25 percent), maternal Group B streptococcal septicemia (GBS) colonization (5 percent), and foul smelling amniotic fluid (3 percent).",
"     </li>",
"     <li>",
"      Only 22 patients (0.8 percent of evaluated infants) had proven sepsis with a positive blood culture, and 40 (1.2 percent) had a diagnosis of probable sepsis based upon a clinical course that strongly suggested the presence of systemic infection (eg, CSF pleocytosis). Of the 62 infants (2 percent) with proven or probable sepsis, 12 were asymptomatic or had transient clinical signs. Four patients with infection died.",
"     </li>",
"     <li>",
"      Multivariate analyses showed that in an initially symptomatic infant, absolute neutrophil counts below 10th percentile for age, presence of meconium-stained fluid, and maternal antepartum temperature greater than 101.5&ordm;F were associated with an increased risk of infection. In infants without maternal intrapartum antibiotic therapy, maternal chorioamnionitis and rupture of membranes &gt;12 hours were associated with an increased risk of infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H734925442\">",
"    <span class=\"h3\">",
"     CDC guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2010, the Centers for Diseases Control (CDC) and Prevention updated guidelines for the prevention of early-onset GBS disease among newborns (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ). The revisions were based on data that had been collected after the issuing of the 2002 guidelines. The intent of the proposed changes was to improve the identification of asymptomatic neonates at risk for early-onset GBS disease and thereby decrease unnecessary evaluation and antibiotic exposure. A retrospective analysis of neonates (gestational age &ge;35 weeks) evaluated for early-onset of GBS disease suggested that a quarter of the evaluations would have been eliminated if the 2010 CDC guidelines were available and used. Half of this cohort received empiric antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The guidelines are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2552?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of the infant whose mother has received group B streptococcal chemoprophylaxis\", section on 'Management approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, a presumptive diagnosis of sepsis, which results in the start of empiric antibiotic therapy, is based upon the presence and timing of neonatal symptoms and risk factors, including the maternal GBS status, a history of maternal fever, prolonged rupture of membranes, and whether the mother received adequate intrapartum antibiotics, if indicated.",
"   </p>",
"   <p>",
"    Our approach in the evaluation and initial management of neonatal sepsis is consistent with the 2010 CDC guidelines for the prevention of early-onset GBS disease among newborns (",
"    <a class=\"graphic graphic_algorithm graphicRef56780 \" href=\"UTD.htm?5/3/5183\">",
"     algorithm 1",
"    </a>",
"    ) and the 2012 American Academy of Pediatrics (AAP) clinical report [",
"    <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/5,56\">",
"     5,56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2552?source=see_link&amp;anchor=H2901877#H2901877\">",
"     \"Management of the infant whose mother has received group B streptococcal chemoprophylaxis\", section on 'Overview of management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic term infant &ndash; The minimal laboratory evaluation for early-onset neonatal sepsis in asymptomatic term infants consists of a blood culture. Some experts also suggest a complete blood count (CBC), including a differential [",
"      <a class=\"abstract\" href=\"UTD.htm?6/16/6410/abstract/40\">",
"       40",
"      </a>",
"      ]. Management of initially asymptomatic infants depends upon the clinical settings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If the asymptomatic infant is born to a mother who has fever (&gt;100.4&ordm;F) before delivery or within 24 hours after delivery; and maternal chorioamnionitis, systemic bacterial infection, or additional risk factors for neonatal sepsis exist, a blood culture is obtained, and empiric antibiotic therapy is started.",
"     </li>",
"     <li>",
"      An asymptomatic infant delivered after membrane rupture &ge;18 hours without maternal fever or other signs suggestive of neonatal sepsis is observed in the hospital for 48 hours. If signs suggesting sepsis develop, a CBC and cultures of blood and CSF are obtained, and empiric antibiotic therapy is started.",
"     </li>",
"     <li>",
"      If an asymptomatic term infant develops signs of sepsis after the initiation of antibiotics, re-evaluation with a CBC, lumbar puncture for cerebrospinal fluid (CSF) culture, and repeat blood culture should be undertaken. Cultures from other sites (ie, urine and skin lesions) should be obtained as clinically indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic term infant &ndash; The minimal evaluation for early-onset sepsis in symptomatic term infants consists of a CBC and cultures of blood and CSF. Further evaluation can include testing for inflammation (eg, C-reactive protein). Empiric antibiotic therapy is started.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For a term infant with signs suggestive of late-onset sepsis, the minimal evaluation includes a CBC with differential and cultures of blood, CSF, and urine. As indicated, cultures of sites such as skin lesions, bone, joint or peritoneal fluid also should be obtained. Empiric antibiotic therapy is started.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the findings are nonspecific, it is often difficult to differentiate neonatal sepsis from other diseases. As a result, empiric antibiotic therapy is started until blood culture results are available.",
"   </p>",
"   <p>",
"    The differential diagnosis for neonatal sepsis in the term or near-term infant generally includes the following systemic infections. Appropriate culture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serology distinguish these infections from neonatal sepsis.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Viral infections &ndash; Enteroviruses, herpes simplex virus, cytomegalovirus, influenza viruses, respiratory syncytial virus, etc",
"     </li>",
"     <li>",
"      Spirochetal infections &ndash; Syphilis",
"     </li>",
"     <li>",
"      Parasitic infections &ndash; Congenital malaria, toxoplasmosis",
"     </li>",
"     <li>",
"      Fungal infection &ndash; Candidiasis",
"     </li>",
"     <li>",
"      Other bacterial infections include urinary tract infection (particularly in the setting of a congenital genitourinary tract malformation), osteomyelitis or septic arthritis, pneumonia, and tuberculosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other diagnoses that may present with similar nonspecific findings of neonatal sepsis include neonatal hypoxia, in-born errors of metabolism, cyanotic congenital heart disease, and neonatal respiratory distress. The clinical history and course of disease distinguish these disorders from neonatal sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=see_link\">",
"       \"Patient information: Sepsis in newborn babies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the incidence of sepsis in term and late preterm infants is low, the potential for serious adverse outcomes, including death, is of such great consequence that caregivers should have a low threshold for evaluation and treatment for possible sepsis in any infant regardless of the birth weight or gestational age. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonatal sepsis is classified by the infant's age into early-onset sepsis (&le;3 to 7 days) and late-onset sepsis (&gt;3 or 7 to 28 days). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early-onset sepsis is caused by maternal vertically transmitted bacteria acquired either in-utero or during vaginal delivery. Late-onset sepsis can be acquired vertically at birth or horizontally from care providers or the environment. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Group B Streptococcus (GBS) and Escherichia coli are the most common bacteria causing neonatal sepsis (",
"      <a class=\"graphic graphic_table graphicRef61061 \" href=\"UTD.htm?39/3/39996\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Etiologic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for neonatal sepsis in term and late preterm infants include intrapartum maternal temperature &ge;38&ordm;C (100.4&ordm;F), chorioamnionitis, five minute Apgar score &le;6, maternal GBS colonization, and membrane rupture &ge;18 hours. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Maternal and neonatal risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations are nonspecific and include fetal and neonatal distress; temperature instability (usually fever); and respiratory, gastrointestinal, and neurologic abnormalities (",
"      <a class=\"graphic graphic_table graphicRef72985 \" href=\"UTD.htm?37/52/38731\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of neonates with suspected sepsis should include a prenatal history, delivery, complete physical examination, and a laboratory evaluation that minimally includes a blood culture. Other laboratory tests include a complete blood count (CBC) with a differential, lumbar puncture prior to antibiotic therapy to determine whether meningitis is present, urine culture for infants &gt;6 days of age, and culture of any other potential foci of infection (eg, pustule). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The isolation of a pathogen from a blood culture is the only method to confirm the diagnosis of neonatal sepsis. A composite of clinical and laboratory findings are used to identify infants with a high suspicion for sepsis, and who are treated empirically until culture results are available. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The differential diagnosis of neonatal sepsis includes other systemic infections, neonatal hypoxia, in-born errors of metabolism, and neonatal respiratory distress.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Edwards MS, Baker CJ. Sepsis in the Newborn. In: Krugman's Infectious Diseases of Children, 11th ed, Gershon AA, Hotez PJ, Katz SL (Eds), Mosby, Philadelphia 2004. p.545.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/2\">",
"      Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/3\">",
"      Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121:689.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Infectious Disease American Academy of Pediatrics. Group B Streptococcal Infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK, Baker CJ (Eds), American Academy of Pediatrics, Elk Grove Village 2012. p.680.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/5\">",
"      Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129:1006.",
"     </a>",
"    </li>",
"    <li>",
"     Nizet V, Klein JO. Bacterial sepsis and meningitis. In: Infectious diseases of the Fetus and Newborn Infant, 7th ed, Remington JS, et al (Eds), Elsevier Saunders, Philadelphia 2010. p.222.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/7\">",
"      Bailit JL, Gregory KD, Reddy UM, et al. Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 2010; 202:245.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/8\">",
"      Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990; 162:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/9\">",
"      Cohen-Wolkowiez M, Moran C, Benjamin DK, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 2009; 28:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/10\">",
"      Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/11\">",
"      Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/12\">",
"      van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, et al. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010; 97:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/13\">",
"      Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010; 125:e1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/14\">",
"      Bauserman MS, Laughon MM, Hornik CP, et al. Group B Streptococcus and Escherichia coli Infections in the Intensive Care Nursery in the Era of Intrapartum Antibiotic Prophylaxis. Pediatr Infect Dis J 2012.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus 2000. file://www.cdc.gov/abcs/reports-findings/survreports/gbs00.pdf (Accessed on March 29, 2013).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2011. 2012. file://www.cdc.gov/abcs/reports-findings/survreports/gbs11.pdf (Accessed on March 29, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/17\">",
"      Stoll BJ, Hansen NI, S&aacute;nchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/18\">",
"      Wu JH, Chen CY, Tsao PN, et al. Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan. Pediatr Neonatol 2009; 50:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/19\">",
"      Kuhn P, Dheu C, Bolender C, et al. Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics. Paediatr Perinat Epidemiol 2010; 24:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/20\">",
"      Schrag SJ, Hadler JL, Arnold KE, et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006; 118:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/21\">",
"      Gottlieb SL, Newbern EC, Griffin PM, et al. Multistate outbreak of Listeriosis linked to turkey deli meat and subsequent changes in US regulatory policy. Clin Infect Dis 2006; 42:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/22\">",
"      Okike I, Lamont R, Heath P. Do We Really Need to Worry About Listeria in Newborn Infants? Pediatr Infect Dis J 2013; 32:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/23\">",
"      Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/24\">",
"      Gordon A, Isaacs D. Late onset neonatal Gram-negative bacillary infection in Australia and New Zealand: 1992-2002. Pediatr Infect Dis J 2006; 25:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/25\">",
"      Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants &gt;/=2000 grams at birth: A population-based study. Pediatrics 2000; 106:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/26\">",
"      Soman M, Green B, Daling J. Risk factors for early neonatal sepsis. Am J Epidemiol 1985; 121:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/27\">",
"      Osborn LM, Bolus R. Temperature and fever in the full-term newborn. J Fam Pract 1985; 20:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/28\">",
"      Voora S, Srinivasan G, Lilien LD, et al. Fever in full-term newborns in the first four days of life. Pediatrics 1982; 69:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/29\">",
"      Herbst A, K&auml;ll&eacute;n K. Time between membrane rupture and delivery and septicemia in term neonates. Obstet Gynecol 2007; 110:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/30\">",
"      Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011; 128:e1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/31\">",
"      Kurlat I, Stoll BJ, McGowan JE Jr. Time to positivity for detection of bacteremia in neonates. J Clin Microbiol 1989; 27:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/32\">",
"      Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996; 129:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/33\">",
"      Garcia-Prats JA, Cooper TR, Schneider VF, et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000; 105:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/34\">",
"      Newman TB, Puopolo KM, Wi S, et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/35\">",
"      Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/36\">",
"      Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/37\">",
"      Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/38\">",
"      Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008; 28:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/39\">",
"      Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics 2004; 113:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/40\">",
"      Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/41\">",
"      Russell GA, Smyth A, Cooke RW. Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection. Arch Dis Child 1992; 67:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/42\">",
"      Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/43\">",
"      Malik A, Hui CP, Pennie RA, Kirpalani H. Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis. Arch Pediatr Adolesc Med 2003; 157:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/44\">",
"      Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/45\">",
"      Ehl S, Gering B, Bartmann P, et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/46\">",
"      Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 2008; 21:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/47\">",
"      Panero A, Pacifico L, Rossi N, et al. Interleukin 6 in neonates with early and late onset infection. Pediatr Infect Dis J 1997; 16:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/48\">",
"      Sherwin C, Broadbent R, Young S, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol 2008; 25:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/49\">",
"      Maniaci V, Dauber A, Weiss S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008; 122:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/50\">",
"      Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med 1999; 153:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/51\">",
"      Stoll BJ, Hansen N, Fanaroff AA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004; 113:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/52\">",
"      Garges HP, Moody MA, Cotten CM, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics 2006; 117:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/53\">",
"      Visser VE, Hall RT. Urine culture in the evaluation of suspected neonatal sepsis. J Pediatr 1979; 94:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/54\">",
"      Flidel-Rimon O, Galstyan S, Juster-Reicher A, et al. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr 2012; 101:e540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/55\">",
"      Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol 2013; 33:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/16/6410/abstract/56\">",
"      Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5043 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-FCC50AAECF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6410=[""].join("\n");
var outline_f6_16_6410=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Early-onset sepsis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Late-onset sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Fetal and delivery room distress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Temperature instability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Maternal and neonatal risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Blood culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H686757573\">",
"      - Complete blood count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H686757902\">",
"      Total neutrophil count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H686757909\">",
"      I/T ratio",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other blood tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Urine culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H686757402\">",
"      - Other sites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H686757410\">",
"      - Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H734925442\">",
"      - CDC guidelines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5043\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5043|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?5/3/5183\" title=\"algorithm 1\">",
"      Secondary prevention early-onset GBS disease among newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5043|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/42/26286\" title=\"figure 1\">",
"      Range of neutrophil count in term neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/42/39586\" title=\"figure 2\">",
"      Normal range of neutrophil counts for preterm infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/2/7215\" title=\"figure 3\">",
"      Manroe normal neonatal neutrophil count",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5043|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/3/39996\" title=\"table 1\">",
"      Bacteria sepsis term infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/52/38731\" title=\"table 2\">",
"      Findings neonatal sepsis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24922?source=related_link\">",
"      Assessment of the newborn infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19354?source=related_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21768?source=related_link\">",
"      Clinical features and diagnosis of meconium aspiration syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10054?source=related_link\">",
"      Evaluating diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/16/18698?source=related_link\">",
"      Group B streptococcal infection in neonates and young infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=related_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22713?source=related_link\">",
"      Late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2552?source=related_link\">",
"      Management of the infant whose mother has received group B streptococcal chemoprophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/40/24202?source=related_link\">",
"      Overview of the general approach to diagnosis and treatment of fetal cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/62/23521?source=related_link\">",
"      Patient information: Sepsis in newborn babies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40550?source=related_link\">",
"      Strategies for the evaluation of fever in neonates and infants (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26200?source=related_link\">",
"      Treatment and outcome of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/59/14264?source=related_link\">",
"      Urinary tract infections in newborns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_16_6411="Normal high blood pressure definitions PI";
var content_f6_16_6411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F59480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F59480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Definition of normal and high blood pressure",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Level",
"       </td>",
"       <td class=\"subtitle1\">",
"        Top number",
"       </td>",
"       <td class=\"subtitle1\">",
"        Bottom number",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        140 or above",
"       </td>",
"       <td>",
"        90 or above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prehypertension",
"       </td>",
"       <td>",
"        120 to 139",
"       </td>",
"       <td>",
"        80 to 89",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        119 or below",
"       </td>",
"       <td>",
"        79 or below",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    \"Prehypertension\" is a term doctor or nurses use as a warning. People with prehypertension do not yet have high blood pressure. But their blood pressure is not as low as it should be for good health.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6411=[""].join("\n");
var outline_f6_16_6411=null;
var title_f6_16_6412="Classification of pityriasis rubra pilaris";
var content_f6_16_6412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"20%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"40%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        PRP type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical characteristics",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prognosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I (classic adult)*",
"       </td>",
"       <td>",
"        Wide distribution of follicular papules and plaques with cephalocaudal progression and sparing islands of normal-appearing skin",
"       </td>",
"       <td>",
"        Favorable - 80 percent of patients resolve spontaneously within three years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II (atypical adult)",
"       </td>",
"       <td>",
"        Ichthyosiform dermatitis, palmoplantar hyperkeratosis, chronic course",
"       </td>",
"       <td>",
"        Chronic course",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III (classic juvenile)",
"       </td>",
"       <td>",
"        Wide distribution of follicular papules and plaques with cephalocaudal progression and spared islands of normal-appearing skin",
"       </td>",
"       <td>",
"        Often remission after one year",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV (circumscribed juvenile)",
"       </td>",
"       <td>",
"        Circumscribed lesions restricted to the elbows and knees and frequent palmoplantar hyperkeratosis",
"       </td>",
"       <td>",
"        Unclear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V (atypical juvenile)",
"       </td>",
"       <td>",
"        Ichthyosiform dermatitis, palmoplantar hyperkeratosis",
"       </td>",
"       <td>",
"        Chronic course",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VI (HIV-associated)",
"       </td>",
"       <td>",
"        Similar to type I",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Most common form of PRP.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Griffiths WA, Ozluer S. [Pityriasis rubra pilaris]. Ann Dermatol Venereol 2001; 128:931.",
"      </li>",
"      <li>",
"       Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5:105.",
"      </li>",
"      <li>",
"       Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010; 11:157.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6412=[""].join("\n");
var outline_f6_16_6412=null;
var title_f6_16_6413="Energy preservation methods";
var content_f6_16_6413=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ways to preserve energy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Basic activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Bathing and grooming",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wash your hair in the shower rather than over a sink.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use a terry robe instead of towels to dry off.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use organizers to keep things within reach.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use a chair in the shower or tub.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use a long-handled sponge or brush to reach your back and feet.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rest elbows on counter or dressing table to avoid leaning unsupported.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use long handled brushes or combs to avoid holding your arms overhead.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use liquid soap or soap on a rope.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use an elevated toilet seat.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Dressing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wear loose clothes that are easier to put on and take off.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bring your foot to your knee to put on socks and shoes so you won't have to lean over.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wear slip-on shoes or shoes with Velcro closures or elastic shoelaces.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use a long handled shoe horn or sock aid.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fasten your bra in front and then turn it around.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wear clothes that button in front rather than pullovers or clothes that button in the back.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use a reacher or dressing stick to help with zippers in back.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Advanced activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Housework",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spread tasks out over the week or month.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hire help.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use long-handled dusters, mops, dust pans.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use automatic washer and dryer if possible.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use lightweight iron.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Shopping",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Make a list.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Organize your shopping list by store aisle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Request assistance in stores.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Have groceries delivered if possible.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Use canned, frozen, or other prepared foods, or try ordering out.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        On days when you feel well, cook extra food and freeze in small containers. Reheat frozen food on days when you're tired.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ask your doctor, nurse, or social worker about community resources that deliver prepared meals.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eat small, frequent meals rather than several large meals each day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Have snack foods readily available.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        If you're really exhausted, put some favorite foods and beverages in a cooler with ice next to you as you rest.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Make quick meals with a microwave or blender.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6413=[""].join("\n");
var outline_f6_16_6413=null;
var title_f6_16_6414="Response to neck immersion";
var content_f6_16_6414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neck immersion and sodium excretion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 245px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of water immersion to the neck on sodium excretion in (a) six normal subjects ingesting 150 meq of Na+ per day and (b) eleven patients with hepatic cirrhosis who excrete little Na+ in the basal state. Sodium excretion tends to be increased in both settings, mediated at least in part by cardiopulmonary receptors sensing the associated expansion of the central blood volume.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Epstein, M, Circ Res 1976; 39:619, and Epstein, M, Pins, DS, Schneider, N, Levinson, R, J Lab Clin Med 1976; 87:822. By permission of the American Heart Association, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6414=[""].join("\n");
var outline_f6_16_6414=null;
var title_f6_16_6415="EB simplex variants";
var content_f6_16_6415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genotypic and phenotypic variants of epidermolysis bullosa simplex (epidermolytic)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Site of cleavage within the epidermis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subtypes",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         Inheritance",
"        </p>",
"        <p>",
"         Mutated gene",
"        </p>",
"        <p>",
"         Targeted gene product",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        <p>",
"         <strong>",
"          Suprabasal",
"         </strong>",
"        </p>",
"        <p>",
"         (cytolysis of suprabasal keratinocytes; intact blisters usually not clinically evident; keratinocytes form numerous interdigitating cellular protrusions; only few desmosomal remnants present)",
"        </p>",
"       </td>",
"       <td>",
"        EB, lethal acantholytic",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal recessive",
"        </p>",
"        <p>",
"         <em>",
"          DSP",
"         </em>",
"        </p>",
"        <p>",
"         Desmoplakin",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Two cases of LAEB have been described",
"          <sup>",
"           [1,2]",
"          </sup>",
"         </li>",
"         <li>",
"          Generalized skin fragility with rapidly progressive epidermolysis and large sheets of detached skin with superficial erosions at birth; skin detachment on hands and feet in a glove and stocking pattern; complete disruption of the epidermal barrier without intact blisters or vesicles; no excessive granulation tissue",
"         </li>",
"         <li>",
"          Universal alopecia (complete absence of scalp hair, eyebrows, eyelashes despite discrete follicular openings on scalp) and nail loss neonatal teeth",
"         </li>",
"         <li>",
"          Involvement of oropharynx, gastrointestinal, genitourinary, and respiratory tract with extensive suprabasal acantholytic separation",
"         </li>",
"         <li>",
"          Demise in neonatal period",
"          <sup>",
"           [1]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         EB, lethal congenital",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal recessive",
"        </p>",
"        <p>",
"         <em>",
"          JUP",
"         </em>",
"        </p>",
"        <p>",
"         Plakoglobin",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          One patient described",
"          <sup>",
"           [3]",
"          </sup>",
"         </li>",
"         <li>",
"          Loss of immunohistochemical reactivity to plakoglobin, desmoplakin, desmoglein-3",
"         </li>",
"         <li>",
"          Generalized erythema and epidermolysis with massive transcutaneous fluid loss",
"         </li>",
"         <li>",
"          Total alopecia, onycholysis",
"         </li>",
"         <li>",
"          No involvement of mucous membranes",
"         </li>",
"         <li>",
"          Proneness to infection (Aspergillus fumigates sepsis), purpura fulminans",
"         </li>",
"         <li>",
"          Massive coprostasis",
"         </li>",
"         <li>",
"          Demise in neonatal period",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectodermal dysplasia-skin fragility syndrome/plakophilin deficiency",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal recessive",
"        </p>",
"        <p>",
"         <em>",
"          PKP1",
"         </em>",
"        </p>",
"        <p>",
"         Plakophilin-1",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Generalized skin fragility with trauma-induced and spontaneous superficial erosions from birth; palmoplantar keratoderma with painful, often disabling fissures (walking, bearing weight); nail dystrophy; alopecia",
"         </li>",
"         <li>",
"          Chronic cheilitis, perioral scale, perioral and lingual fissures",
"         </li>",
"         <li>",
"          Blepharitis, astigmatism",
"         </li>",
"         <li>",
"          Persistent abnormal hair (hypotrichosis, loss of eyelashes, complete alopecia; woolly hair)",
"         </li>",
"         <li>",
"          Esophageal strictures, constipation",
"         </li>",
"         <li>",
"          Growth retardation (usually below the third centile for height and weight)",
"         </li>",
"         <li>",
"          Variable clinical features include scattered scale-crust on the trunk and limbs, follicular hyperkeratosis, inflammatory scaly plaques in flexures, perianal erythema and erosions, pruritus; reduced sweating; dental caries; recurrent systemic infections; chronic diarrhea",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS superficialis",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant",
"        </p>",
"        <p>",
"         ?",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Blistering between stratum corneum and granulosom",
"         </li>",
"         <li>",
"          Superficial erosions with scarring and milia formation from birth or early infancy",
"          <sup>",
"           [4]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"8\">",
"        <p>",
"         <strong>",
"          Basal",
"         </strong>",
"        </p>",
"        <p>",
"         (cytolysis of basal keratinocytes)",
"        </p>",
"       </td>",
"       <td>",
"        EBS, localized, former Weber-Cockayne",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant",
"        </p>",
"        <p>",
"         <em>",
"          KRT5",
"         </em>",
"         ,",
"         <em>",
"          KRT14",
"         </em>",
"         ,",
"         <em>",
"          ITGB4",
"         </em>",
"        </p>",
"        <p>",
"         Keratin 5, keratin 14, integrin&alpha;4",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Most common EBS subtype",
"         </li>",
"         <li>",
"          Mainly limited, regional involvement of palms and soles",
"         </li>",
"         <li>",
"          Clinical onset usually during infancy or, rarely, early adulthood",
"         </li>",
"         <li>",
"          Extracutaneous manifestations (other than clinically insignificant blisters within oral cavity during early childhood) rare",
"          <sup>",
"           [5]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS, Dowling-Meara",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant",
"        </p>",
"        <p>",
"         <em>",
"          KRT5",
"         </em>",
"         ,",
"         <em>",
"          KRT14",
"         </em>",
"        </p>",
"        <p>",
"         Keratin 5, keratin 14",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Generalized, peculiar herpetiform distribution (arcuate grouping) of blisters from birth (typically and best seen when patients have relatively milder disease activity",
"          <sup>",
"           [6]",
"          </sup>",
"          )",
"         </li>",
"         <li>",
"          Atrophic scarring, milia formation, confluent palmoplantar hyperkeratosis, nail manifestations",
"         </li>",
"         <li>",
"          Often mucosal involvement",
"         </li>",
"         <li>",
"          Association with growth retardation, anemia (fatigue, breathlessness, reduced exercise tolerance, poor wound healing, anorexia), constipation, laryngeal stenosis, premature death",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS, other generalized, including former Koebner",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant or recessive",
"        </p>",
"        <p>",
"         <em>",
"          KRT5",
"         </em>",
"         ,",
"         <em>",
"          KRT14",
"         </em>",
"         ,",
"         <em>",
"          COL17A1",
"         </em>",
"        </p>",
"        <p>",
"         Keratin 5, keratin 14, type XVII collagen",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Widespread but less severe form that usually presents at birth",
"         </li>",
"         <li>",
"          Rarely eye involvement",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS with mottled pigmentation",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant",
"        </p>",
"        <p>",
"         <em>",
"          KRT5",
"         </em>",
"        </p>",
"        <p>",
"         Keratin 5",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Skin blistering with reticulate brown skin pigmentation, keratoderma, nail dystrophy",
"         </li>",
"         <li>",
"          Pigmentary lesions usually present in early childhood, but may become less distinctive or even imperceptible by adult life",
"          <sup>",
"           [6]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS with muscular dystrophy",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal recessive (autosomal dominant)",
"        </p>",
"        <p>",
"         <em>",
"          PLEC1",
"         </em>",
"        </p>",
"        <p>",
"         Plectin",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Generalized blistering from birth",
"         </li>",
"         <li>",
"          Atrophic scarring, milia formation, nail dystrophy and loss",
"         </li>",
"         <li>",
"          Granulation tissue formation and stenosis within respiratory tract",
"         </li>",
"         <li>",
"          Muscular dystrophy may either be present on or shortly after birth in a child with severe generalized skin involvement (usually appearing as \"floppy\" babies who are unable to easily lift their arms and legs), or, in others, may arise insidiously in later childhood or adulthood; this variant harbours a higher mortality rate from muscle involvement",
"          <sup>",
"           [5]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS with pyloric atresia",
"       </td>",
"       <td>",
"        <p>",
"         ?",
"        </p>",
"        <p>",
"         <em>",
"          PLEC1",
"         </em>",
"         ,",
"         <em>",
"          ITGA6",
"         </em>",
"         ,",
"         <em>",
"          ITGB4",
"         </em>",
"        </p>",
"        <p>",
"         Plectin, integrin&alpha;6, integrin &beta;4",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Gestational hydramnion",
"         </li>",
"         <li>",
"          Generalized blistering of variable severity from birth, atrophic scarring",
"          <sup>",
"           [7-9]",
"          </sup>",
"         </li>",
"         <li>",
"          Association with aplasia cutis congenital",
"          <sup>",
"           [10]",
"          </sup>",
"         </li>",
"         <li>",
"          Mucosal involvement (protein losing enteropathy, diarrhea)",
"         </li>",
"         <li>",
"          Anemia, growth retardation, contractures, cryptorchidism, high mortality",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS, autosomal recessive",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal recessive",
"        </p>",
"        <p>",
"         <em>",
"          KRT14",
"         </em>",
"         ,",
"         <em>",
"          DST",
"         </em>",
"         <sup>",
"          [11]",
"         </sup>",
"        </p>",
"        <p>",
"         Keratin 14, distonin (BPAG1)",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Generalized blistering from birth (frequently anogenital), ichthyosiform plaques; rarely milia formation or atrophic scarring",
"         </li>",
"         <li>",
"          Involvement of oral cavity (caries) and genitourinary tract",
"         </li>",
"         <li>",
"          Growth retardation, constipation",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EBS, Ogna type",
"       </td>",
"       <td>",
"        <p>",
"         Autosomal dominant",
"        </p>",
"        <p>",
"         <em>",
"          PLEC1",
"         </em>",
"        </p>",
"        <p>",
"         Plectin",
"        </p>",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          Hemorrhagic blisters at predominantly acral sites from birth",
"         </li>",
"         <li>",
"          Onychogryphosis (markedly curved and deformed nails resembling ram's horns)",
"          <sup>",
"           [6]",
"          </sup>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Jonkman MF, Pasmooij AM, Pasmans SG, et al. Loss of desmoplakin tail causes lethal acantholytic Epidermolysis bullosa. Am J HumGenet 2005; 77:653.",
"       </li>",
"       <li>",
"        Bolling MC, Veenstra MJ, Jonkman MF, et al. Lethal acantholytic epidermolysis bullosa due to a novel homozygous deletion in DSP: Expanding the phenotype and implications for desmoplakin function in skin and heart. Br J Dermatol 2010; 162:1388.",
"       </li>",
"       <li>",
"        Pigors M, Kiritsi D, Kr&uuml;mpelmann S, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet 2011; 20:1811.",
"       </li>",
"       <li>",
"        Fine JD, Johnson L, Wright T. Epidermolysis bullosa simplex superficialis. A new variant of epidermolysis bullosa characterized by subcorneal skin cleavage mimicking peeling skin syndrome. Arch Dermatol 1989; 125:633.",
"       </li>",
"       <li>",
"        Lanschuetzer CM, Fine JD. Classification and molecular basis of hereditary epidermolysis. In: Life with Epidermolysis Bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy, Fine JD, Hintner H (Eds), Springer, Wien-New York 2008. p.6.",
"       </li>",
"       <li>",
"        Fine JD. General cutaneous manifestations. In: Life with Epidermolysis Bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy, Fine JD, Hintner H (Eds), Springer, Wien, New York 2008. p.99.&nbsp;&nbsp;",
"       </li>",
"       <li>",
"        Mellerio JE, Pulkkinen L, McMillan JR, et al. Pyloric atresia-junctional epidermolysis bullosa syndrome: Mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease. Br J Dermatol 1998; 139:862.",
"       </li>",
"       <li>",
"        Nakano A, Pulkkinen L, Murrell D, et al. Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype correlations. Pediatr Res 2001; 49:618.",
"       </li>",
"       <li>",
"        Pulkkinen L, Kim DU, Uitto J. Epidermolysis bullosa with pyloric atresia: Novel mutations in the beta4 integrin gene (ITGB4). Am J Pathol 1998; 152:157.",
"       </li>",
"       <li>",
"        Maman E, Maor E, Kachko L, Carmi R. Epidermolysis bullosa, pyloric atresia, aplasia cutis congenita: Histopathological delineation of an autosomal recessive disease. Am J Med Genet 1998; 78:127.",
"       </li>",
"       <li>",
"        Groves RW, Liu L, Dopping-Hepenstal PJ, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 2010; 130:1551.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_16_6415=[""].join("\n");
var outline_f6_16_6415=null;
